[User] <|image|>Identify text in the picture

[Assistant]
<doc> NEW YORK, May 9 (UP)—
 The scientist who produced most
 cancer yesterday offered factual
 evidence that the damage it
 does to the lungs is reversed
 when smoking is stopped.
 Dr. Oscar Auerbach goti his
 new evidence by dissecting the
 lungs of 216°men who: had died
 cancer. Seventy-two had: never
 émoked, 72 were: smokers when
 they died, and. 72 had stopped
 smoking at least five years
 before their deaths.
 _ The sections were examined
 microscopically for cellular
 from continued smokers, 97.8
 per cent revealed _ the
 abnormalities. Of ex-smokers’
 sections 66.6 per cent: revealed
 them andthe total for men who
 per cent. ,
 ‘hew evidente today in a paper
 prepared for the Third Pan
 ‘American Cancer. Cytology
 Congress here. .
 His previous contributions to
 cigaret smoking were detailed
 postmortem microscopic studies
 of thousands of lungs from
 smokers, some of whom had
 revealed consistent celullar
 The most! common
 abnormality was in: the nucleus
 them in 93.2 per cent of the
 sections from smokers and in
 and 12 per cent from
 non-smokers.
 He also found an abnormality
 nuclei” seemed'in the process of
 being destroyed by dis-
 integration. He found them only
 in: sections from ex-smokers —
 43 out of the 72 had them. His
 stopping of smoking had
 permitted body defenses to
 come into play to destroy
 “pre-cancerous” cells,
 FEF9S90STOzZ </doc>


[User] <|image|>Decode text from the snapshot.

[Assistant]
<doc> SSBD0]d M@IAOY SOURWUOLEd SdJOJUIOY
 yeHpng Jo/pue einpeuos ‘edoos ul sebueyyD eroiddy
 Ajjeuonounj-sso1y snsussuody pling
 yebpng pue
 ainpeyos ‘edoos jsurebe ssaibolg MalAoY Aljeolpoued
 (sueuseg aAowel ‘6'9) Japee7 jyoelo1g au} Uoddns
 ebpng - ginpayos - edoos -
 sulbeg Joel01g a10jeq uel, }OalO1Y Jeul4 aAoiddy/meiAey
 Jape] yoaloig (j09|8S) Juloddy
 yeHpng pue eaoelqo psloig eraoiddy/ysiqeisy
 }olO1g OY} JO} ,UOISIA, @ BAQIddY/a}yealD
 YOSNOdS V 4O S310
 2505591640 </doc>


[User] <|image|>Read written language in the visuals

[Assistant]
<doc> athe
 PHILIP MORRIS INTERNATIONAL INCORPORATED
 This questionnaire is long and detailed. | sincerely appreciate the time and effort you
 will take in answering these questions. Its purpose is twofold. First, to get a snapshot
 of what your department/functional group is now doing day-to-day managing records.
 Second, to find out what sort of records management services would be useful to your
 department/functional group.
 The questionnaire is divided into 10 sections plus a Glossary. These are:
 Section Measuring the following
 1. General Background on the department
 2. Records Coordinators Existence and duties
 3. Records Retention Schedules Existence and usefulness
 4. Disposal Suspension Practices and procedures
 5. Media and Technology Types, extent, usefulness
 6. Security Types, extent, usefulness
 7. Active Records Types, extent, ease of access
 8. Inactive Records Types, extent, location
 9. Vital Records Extent, participation in protection programs
 10. Records Disposal Methods employed
 Glossary of terminology
 There are 101 questions and it takes about 20 - 30 minutes to complete.
 The questionnaire should be answered by at least one member of each functional
 group in the department. It should be completed by the person(s) who are actively
 involved in file folder creation, file retrieval, record storage, record retrieval, record
 transfer or disposal suspension. | recommend the Senior Administrative Secretaries,
 Senior Executive Secretaries, Administrative Assistants, Executive Assistants,
 Paralegals, and any staff who coordinate day-to-day records activities as good
 candidates to complete the questionnaire. There may be others in the department who
 would be more suitable.
 The questions are hopefully self-explanatory. Attached is a brief glossary of terms.
 The questions can be answered with YES/NO, Ranking, Pick Lists, or brief
 descriptions. In a few cases, DN’T KNW is an option. Please try and answer as many
 questions as possible. If you are unable to answer the question, leave it blank.
 The questionnaire should be returned to PMI-Legal, Francine de Boer, by March 29. |
 will arrange individual meetings with each department the following week.
 If you have any questions please contact me, Bill Proudfit, at PMI-Rye Brook Legal
 Department, 914-335-9516.
 Thank you very, much jor tabing the time to complete the questionnaire! %
 : cn
 mo. </doc>


[User]
<|image|>Parse the text behind: <doc> uolyoadsuy
 SOIAHoy Punecee sjo7UuCy
 Mo .
 gQuRicessy $]090]}01q BuIseUuas
 uolyoadsu| 9
 sjuaWaJINbay
 uonoadsu| sjevereyy
 jeul4
 uonoedsu| ualeplleA 9

[Assistant]
 $$3901q-U] en
 S OULU
 BSOOO el Oy v
 «< SIB]BWeIe 9 SUdIeEOWINedS
 UONONPCA — siooood | :
 uanoadsuy 9
 sjuaWauInbay sJUsLUSZINDSY Jesn
 SS38901q 9 JONPAd
 asn
 pepus}u|
 WwBIOBICl UONORIOIU!
 “9SN Popusjul Ojloods JO}
 sjuswealInbel Je;nojed ** Jaunsuo4
 2078609163 </doc>


[User] <|image|>Deciphering written content in the photo.

[Assistant]
<doc> tye
 “1.0
 2.0
 3.0
 5.0
 6.0
 7.90
 8.0
 9.0
 10.0
 11.0
 12.0
 INTRODUCTION e e e » e e e
 PART A_: BENCH SCALE TESTWORK
 OBJECTIVES ... eee ee
 TEST FACILITIES ......
 EXPERIMENTAL PROCEDURE . .
 TEST RESULTS 5 wee eee
 DISCUSSION OF RESULTS ...
 PART B : PILOT SCALE TESTWORK
 OBJECTIVES se ee ee we
 TEST FACILITIES .. +e «
 EXPERIMENTAL PROCEDURE ee
 TEST RESULTS ec ee eee
 DISCUSSION OF RESULTS ...
 CONCLUSIONS eee ee ee oe
 18. + 19
 20: + 21
 00v..pZ0Z02 </doc>


[User] <|image|>Deciphering written content in the photo.

[Assistant]
<doc> Purpose: @fandard Configuration © Reduced W7M Won Number 2 Ors
 om - os Date of Run: 10-05-87
 Page 1 of 2
 SAMPLE TYPE : ~ > OU, % PH % Nictn (DWB)
 Feed Filler 15.3@ 1.795
 12.28 1.801
 _Avg= 13.79 1.788
 Ordered Filler 28,37
 . - 28.68
 27.57
 fivg= - 28.24 -
 Extracted Filler (As-Is [Top] 3@.4)
 27.48
 fAivg...{Top Sect.J= 28.95
 Extracted Filler (As-Is)[Bot] 27.84
 29.17
 -Avg...[Bot Sect.J= 28.51
 Extracted Filler (Ory) 12.53 Q.946
 13.16 @.958
 14.91 @.@59
 14.57 9.959
 Avg= 13.79 %.956
 KKEKEERKRKEKREKRKEKRERKERKEEKEE
 ; gtin Redu mn=d7h_ ©
 KEELE EEE REE EEE EEE EEE EE EERE
 Feed Stem 35.60 0.638
 35.98 2.625
 Avg= 35.79 @.628
 Spent Stem [Ads #1](Bot Basket] 37.@2 8.572 gé----Top
 32.44 0.562
 36.86 @.554
 55.65 __@.606 f-77 Bot. _
 fivg...-(Bot Basket Sect.J= 35.49 @. 574
 Spent Stem [Ads #Z][Bot Basket] 36.14 @.532 €-~---Top
 35.93 @.577
 35.63 @.575
 35.6 Q.599 f-~—-Bot
 fivg...{Bot Basket Sect.]= 35.84 @.569
 M/M= (Step #1236) 7 (Step #2=94) 3 (Total=13@)
 MF w/o AC ; UBFSS Stem Type
 Filler/Ads #1/Ads #2=9/4/4
 AB=13.1 % (219 1b Water + 33 lb AB)
 Filler heavily Impreognated: Stem not Compacted (very loose)
 COZ Flow =8@@ 1b/min
 Auto-Bata collection Started
 EPA EZOSOS
 Lai |
 Maid </doc>


[User]
<|image|>Continue reading the text: <doc> B11 Di MR
 DRVK/MR
 3. Juli 1979
 BIOASSAY: Lipid content and distribution
 MAIN HEADING: Lung cytochemistry
 (free lung cell responses)
 PRIORITY: ty Hh, HH
 SAMPLE (1) purified alveolar macrophages
 MATERIAL: (2) lavaged lung
 (3) type 2 epith. cells
 (4) lung lavage supernatant
 METHODS : Separation of alv. macrophages from other free lung cells
 (see "celi-density and -size"), extraction of cytoplasmic lipids,
 (1) analysis of (a) total lipid content (i) biochemically,
 (ii) histochemically
 (b) contribution of phospholipids, triglyce~
 vides and other lipid classes to total
 lipids by thin-layer chromatography
 (2) determination of lipid-vesicle size and number
 EQUIPMENT: Ultracentrifuge: avail.
 Microscope: avail.
 TLC-equipment: avail.
 Image analyzer: budget 1980
 CW: avail.
 JUSTIFICATION: own results:
 no results

[Assistant]
available
 other cig.-smoke related results:
 Using morphometry it was shown by Davbies et al, that after
 60 and 90 day exposure to sitoke in rat alv. macrophages there
 was a massive increase in the volume proportion of cytoplas-
 mic lipid inclusions (0.5 - 16 %). Increase of cytoplasmic
 lipid also observed with alv. macrophages in human smokers.
 need for new approach:
 Observed increase in cell size and decrease of density is in
 aggreement with assumption of increased lipid content of ma~
 crophages after smoke exposure. Quantitative determination of
 more than ten-fold increase of lipid content may be superior
 to determination of slight increase of cell density.
 PROBLEMS : -
 INVESTMENT: (a) material: 4, CHE, Het
 (b) training: +, tty H+
 ESSA TT620e </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> Bue juous SADUVL ATISSM "DAV .SNId NOLLVHOLSSY. OV +
 eo UeIeLIG
 sayes Ajyuoyy jemoy
 Zoo [205 sNjq VOIZEI03seq
 bor Bet get Se+ opt sauaaiq
 9S tot Oot ost gL Sais AINSBAA [eNloW
 cel el zél web vit v8 Shig “oIsey FMA “BN
 ye On ef IM ze MM LEA pez +6 ‘OL
 + OF
 + OF
 + OOL
 OzL
 Ort
 OGL Ogl
 LoL ob
 * OBL </doc>


[User] <|image|>Translate text in the picture.

[Assistant]
<doc> FROM: K. A. SPARROW ; NOV 22 |X FEB 14
 , DEC 20 APR 11
 commen ae ene ea
 SUBJECT: HARLEY-DAVIDSON CIGARETTES PROGRESS REPORT
 Pre-Sell has been much more successful with this brand than any other | have seen in 14 years. Chain force-outs
 were timely and we encountered relatively few accounts which did not receive product.
 % OF DISTRIBUTION ACHIEVED IN RETAIL OUTLETS:
 0% CLASSIFIED CALLS ;
 “9% ANNUAL CALLS 4
 soy
 PROMOTIONAL IMPACT:
 $.50 OFF PACK: On target. Any amount fess than 50 Cents would not generate trial and sales. This
 offer is moving product.
 SALES FORCE 20'S: Good. This tool is helping generate immediate interest in Harley.
 vOoRSOZ4
 $5.00 OFF CARTON: Ontarget. The $5.00 Coupon is generating limited carton sales. Any amount less than
 this would not “pull in* the price conscious smoker. , _ </doc>


[User] <|image|>Detect words in the photograph.

[Assistant]
<doc> INFACT
 256 Hanover Street « Third Fioor
 * Boston, MA O2113 » 617/742-4583
 fae nA pe Sai EEN
 For immediate release Contacts: Kelle Louailller (617) 742-4883
 April 29, 1994 Elaine Lamy (617) 741-4583
 INFACT Chatlenges Tobacco Industry,
 Launches Internations! Boycott of Philly Morris and
 Retall Drive to Get Rid of Jou Camel
 The consumer activiat organization INFACT recently announced the next step in ite Tobacco
 Industry Campaign, kicking off two new tactics to challenge the industry's aggressive promotion of tobacco
 addiction around the world, especially to children and young people. On April 19, INFACT called on
 ‘onsumers to beycoit industry leader Philip Morris' {cod prcduces (including Keait, Oscar Mayor and Post
 cereals), and called on retailers not to display RJR Nabisco's Joe Came! cartoon character in their stores.
 “For years the tobacco industry has been blasted for its powerful role in promoting iw deadly and
 addictive product," said INFACT's Executive Director, Elaine Lamy. “Every day we learn more about just —
 how far this industry goes to protect its profits ~— manipulating levels of nicotine in cigarettes to keep-
 people addicted, adding dangerous chemical substances during the manufacturing process, suing the
 reporters, researchers and hoalth officials who expose these abuses. It's time for peaple around the world to
 take action and hold companies like RIK Nabisco, and Philip Morris directly accountable."
 INFACT’s purpose iz to stop life-threatetting abuses of transnational corporations and increase their
 accountability to people around the world. The organization is known for the Nestle Boycott, the campaign
 that in 1984 won significant reforms in Neatle's marketing of infant formula, and the GE Boycott, which last
 year pushed industry leader General Electric out of the nuclear weapons-business. INFACT is calling on the
 tobacco industry ta: .
 stop marketing and promotion that eppeals-to children and young people;
 stop spreading tabacco addiction around the world;
 stop influencing and interfering in public policy;
 stop deceiving people about the dangers of smoking;
 pay the high-costs of health care associated with the tobacco epidemic.
 Every year, 3 million people around the world die from tobacco-related diseases. In the US, smoking is
 the leading preventable cauze of death, killing 419,000 people in 1991. In spite of overwhelming evidence
 demonstrating tobacco's deadly effects, the tobacco industry will spend over 4 billion dollars this year to
 advertise and promote its products around the world. Since 50¥e of smokers start before the age of 2{ —- 60%
 before the agewof 14 — mast of this money goes into ads and promotions geared toward children and youth.
 US Surgeon General Joycelyn Elders has pointed to Philip Morris's Marlboro Man as a classic
 example of youth marketing, playing on the themes of risk-taking and independence. The cowboy image
 oe. @ 8 8
 —MORE—
 y9ZerseLloz </doc>


[User]
<|image|>Read the following text: <doc> 224604 PP- Fone
 BETES «
 Objective
 to determine if the heaters contribute a measurable portion
 of any of

[Assistant]
the target elements (As, Zn, Cd, Cr, Pb, Hg, and
 Ni) to the content of that element in URSUS smoke
 CLLESESZO% </doc>


[User]
<|image|>Continue reading the text: <doc> ope 2029046511
 paioqys sdnoif 198yjo [Te Jo azesuepucg *aperHTWUeo seaibep y je pesoys aqesuapuoo (vx)
 GOTudd NOLILWOIIddY JO 08 SSSEM “NT ALITIGvwd0ud YOWNAL
 . ‘ c aundoId Ad
 ( (482M X asnow) /6u) ALVYSNAONOD ANd
 OZL OOL 08 09 OF 0z 0
 | | J | I I |
 — 0
 : tH OC
 E Lop
 3 - C
 5 c
 L - Fu
 s a VaWd SM1d I-OSMW ot ae ~
 o I-OSMW & we 09
 8 }4C39¢8 &
 a , >
 5 vaWd Said I-agSsMs ' g—— ©
 = I-DSMS *§ O— |og 7
 Z VEWd snid [-9SMW * pH—— a
 g (®@) I-OSMN * @— x
 © I-OSMW * o—— _

[Assistant]
 8 Lda 3
 = OOL ~
 W %LLESOH FLIL LLWUPOLVHN 890£/00S0 d LuOdauans
 ABSA OR Ws SLA. Lea GLA CZLeOAM fmanrvanen ot
 BTR </doc>


[User] <|image|>Retrieve written information from the image.

[Assistant]
<doc> * , a
 PHILIP MORRIS USA INTER- OFFICE CORRES PONDENCE
 120 PARK AVENUE, NEW YORK, NY 10017-5592
 TO: Ed Gee DATE:
 FROM: Karen Eisen
 SUBJECT: Weekly Highlights
 MAT
 We are continuing to track Mat Module has been shortened.
 MAT Catalog Quantitative Test
 Currently in field. We are looking at catalogs 1,2 3 and comparing
 them to Camel Gash catalog. Findings will be available late this
 month,
 MAT. 1 Direct
 Report based on the first few cells has been issued.
 MAT 2 Direct
 MAT 2 is mailed out. A questionnaire is being finalized and a sample
 _is being pulled.
 Presentation
 For anyone interested, we are collecting all information from the
 moment we got involved in Adventure team through March.
 Hopefully it will show what we have done right and what we have
 done wrong so that future mega promotions can go smoother.
 RACING
 In-depths were conducted 4/21 and 22 in Pittsburgh. Respondents
 were exposed to the racing ads and the new catalog. Results were
 communicated informally. Report will be issued this week.
 LIFESTYLE STUDY 1& 2
 2¥0899070E
 Nat is presenting YAMS to Morgan today. We met with MISI to
 review the new Lifestyle study. The study will be conducted among
 18-49 year olds . A meeting will be set up for sometime next week </doc>


[User]
<|image|>Parse the text behind: <doc> COLLEGE OF TOBACCO KNOWLEDGS
 November 16-17, 1981
 PARTICIPANTS
 J. Mark Ahearn
 Manager, Communications, Brown & Williamson Tobaceo Corp
 Michael A. Bateman
 Manager, Minority Affairs, Brown & Williamson Tobacso Core.
 Kenneth P, Baxter
 Director, Corporate Affairs, Philip Morris, Australia, Ltd
 Delanne Bernier
 Coordinator, Legislative Tracking System, Philip Morris Ine
 Irene Bick
 Planning Anaylst, Philip

[Assistant]
Morris Inc., New York
 Carolyn Bleckwehl
 Major H. Bowes
 General Manager, Lorillard Ine., Greensbora, N.C.
 rre Brochu
 Management Trainee, Philip Morris International
 Galen R. Burgess
 Manager, Drug Accounts, Philip Morris Ine
 Sara Byrd
 Accounting Manager, Tne Tobacco Institute, Washington, D.C.
 Brooke 4. Cheney
 State Director, Ohio, The Tobacco Institute, Cclumbus, Ghio
 Brenda B. Clark
 Assistant Librarian, The Tobacco Institute, Washi
 rgton, D.c.
 Barbara Cline
 Payroll Supervisor, The Tobacco Institute, Washington, D.C.
 Jeannette Cohen
 Reference Librarian, The Tobacco Institute, Washington, D.C,
 David L. Connor
 Agricultural Services Specialist, Phitip Morris U.S.A.
 Roland Corradini
 Senior Analyst, Infotab, Brussels, Belgium
 Antonietta Corti
 Director of Informaticn Services, Infotab, Brussels, Belgium
 COOL TOGS </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> MEMORANDUM
 10: rand Groxp f\ 52
 FROM: BR. O. Stewart cel
 lun
 3 August 10, 1977
 Areas of Execution
 The responsibility uf he quality uf what the cuasumer sees in print must fall on
 the Product Manager as press proots anc fimal direction are noi available to other
 Teves, I feel thas it is inappropriate anc will be devastating to require departmental
 approval cf press prozfs, Therefore. individual Product Managers should be
 thoroughly satisfied with the resulting qualities that will be -eccived and seek counsel
 if there is a lack of confidence, perhaps cancelling and requesting another brand ta
 take its place if its space is teyond cancellation in order to reserve cur quality image.
 ‘Where the possibility exists that the execution will not be tota‘ly satisfactory, perhaps
 resulting from the elements being used for magazine not being suitable for outdoor, [
 would like this hranght ta my attention. Where it is heyond comrol that our expezted
 quality is not mainteined, I would Mke notification of the preblem ard cireumstenecs
 relaied to both myself and Al Nagle.
 Iam not satisfied with our quality of outdaor, but there is both room for improvement
 for the graphics and also the ovtdoor production. D:ck Veatch is coordinating this
 activity with Purchesing and PKC, but I vould like a major efvort on the Brand Grcup!s
 behalf te assure that the agencies do cxecute for outdoor specifically; aad if this
 requires criginal art or new treatment, chis should be shewn in your timetabie and
 plas, Should we continue to show poor performance in this area, { would expect that
 we would undertake cancellations of owdoor, which the individual brancs may find
 extremely burdensome.
 RO. &
 ROSipde
 o6zz0
 T0893 </doc>


[User]
<|image|>Continue reading the text: <doc> . 2028744828
 } ‘
 g | NNYWNNGQ@ °W ;
 0362 : | . N3LSC¥ “NIG OS
 S ~~. T00/60525S aquyv 39viIrig
 seel | 80s | SESE G¥EX13 T00/99Z79SS |G 19 LYSS¥d MA
 ee | AVV1dH3WNINN LOVHINOO OINLH3IOA
 zS°6T WAL . ——%S*ET VAL anovid LV LNOOD ZINDNIBA
 ISfiudynnH | *Z43A °0NO . — :
 : €66T YIIILGIS ONVWA YOOA LIv4yO4 ;
 _ ey —_— a _ . 7. vo
 $89se0Sey |-a8 E6/60/T) 9929 . |. EE999- NEIWYSL JONI unnLavd
 UN MLO, WNLWG {-. inva =: | §NANaWNyOA —Tnawnoa ve .
 _ VALON _aiva | aNamoeN | eNANaWNOCa | ANAWNOOG |,
 Bo, FAN fs NERS waadgvey Ce a
 , ——4 / ~ . os ,
 | #30 10K— ~suahais- “LNIS ZE6T}

[Assistant]
a oy
 “sere ae (Stor ANWTGd , .
 ISipg .
 a ad
 ~ In IAS ‘ 1 ‘
 OM © yRINa HOaVISIY °LNOD </doc>


[User] <|image|>what is written in the image?

[Assistant]
<doc> Project # 7036
 Incerviewing begins: 3/5/93 INTERVIEWER: Do Not Comp iate
 Helle, Xm. rm working on & survey www. 1 12345 67890
 of public issues for the Becker Institute _WCOL. 2 12345 67899
 of Bostom and 1 would like to get your ~coL. 3 12345678990
 opinion on some questions, COL, 4 1234 567890
 COL, 5 412345678 9 0
 Ara you 13 years af age or older? INTERVIFVER: Complete
 (If answer is "no," aak to spaak to
 poweone who is over 18.) COL. _6_ L Male 2 Female
 cOL..2. Gewnary COL._8.
 1 Addison 1 Rutland
 2 Bennington 2 Washington
 3 Caledonia 3. Windham
 4 Chittenden & Windser
 5 Essex
 6 Frankiin-Grand Isle
 7 Tamotile
 8 Orange
 9 Orleans
 (DO NOT READ LIST.)
 In your opinion, what are the one or two coL. 9
 most serious problems facing the state of 1 Protect The Environment
 Vernont today thet you would like the 2 Put More Restrictions On
 governor and the state Legialature to deal Cigarette Smoking
 with as their top priorities? What are the 3 Gontrol Growth & Development
 most important things the governor and the 4 Improve Education
 Legislature should do this year? (WRITE 5 Hold Down State Taxes
 COMMERTS BELOW AND CIRCLE APPROPRIATE G Encourage Economic Development
 HUMBER TO RIGHT) ? Balance Budget
 8 Hold Down Property Taxes
 § Alcohol/Drug Abuse
 0 Health Care & Health Insurance
 Costs
 X Other
 (Specify)
 Y Don’t Know, No Opinion
 How serious would you say the problem of the cou. 19.
 prasanca of tobacco amoke in indeor public 1 Very Serious Problem
 places in Vermont ts today? Would you say 4 Fairly Serious Problem
 “hia {s a very sertous problem, 4 fairly 3 Not Much Of A Probles
 serious problem, not much of a problem, or 4 No Problem At All
 Ls it ne problem at all. to you? § Don’t Know, No Opinion
 Kow high ox low a priority ia it to you for COL. bh
 atate government Co completely ban smoking 1 Very High Priority
 in all public places in Vermont -- would you 2 Fairly High Priority
 say this is a very bigh prioxvity, fairly 3 Middle Priority
 high priority, a middie prioxity, a fairly 4 Fairly Low Priority Ro
 tow priority, or a very low priority? 5 Very Low Priority S
 6 Don't Know, No Opinion pie
 ey?
 “ i
 How doa you Feel about the present COL.14_. Ww
 restrictions on smoking chat exist where you 1 Satisfied CS
 live and work? Axe you satisfied with these 2 Yoo Restrictive
 smoking, restrictions as they are, are thay 3 Should Be More Restrictive oe
 beg xestrictive, oF should they be more & Don’t Know, No Opinion wo
 restrictive? </doc>


[User]
<|image|>Parse the text behind: <doc> 7 AU RLH TOV EH BH WY
 a major breducth rough inf full fl avor,
 ¢ jow-tarsmokingenjoyment. —
 - Tobacco.
 New Prime gets to be low in tar by just
 ‘doing what Comes naturally.
 ee Most of today’s low tar cigarettes doa lot of talking
 mon 7 about charcoal filters. reeessed tips, high porosity paper.
 Aye el Everything but tobacco. (You remember tobacco —
 re po” (he stuf smoking pleasure was made of)
 ee SS xy New PRIME is different. We tath about g
 a tobacco, because we have something to talk about: a blend Ay
 es based on naturally low tar tobacces. They're the tobaceos BF
 . specially picked from the “low tar zone” of the plant. ! !

[Assistant]
 Sure. il fakes extra eare to pick just the right tobuceos. 77 rig t .
 But it’s worth it to make a cigarette that vives you full, ! ff
 5 unadulterated natural tobacco flaver, And only 9 mg. tar. I LZ {
 -~ Once we've made Prime the most naturally satis-
 fying low tar cigarette, we're not satisfied. ney
 We don’t stop with just giving you naturally
 flavorful. low-tar tobaccos— not wheo there's a7
 even more richness available fron’; wy
 nature. The richness of a unique Ores en ; .2 a Ny
 ' RAVALA aromatic tobacco called me iy aU in, sae et i oes
 Kavala. Adding a touch of Kavala
 * fo PRIME's natural tobacco blend
 we 7 Brings out the flavor.
 7” Amptifies it, And makes the good
 natural taste even better.
 Experience the cigurette with
 the naturally low-tar tobaccos and
 the “Kavala touch” for yoursell. And
 , Feturn to nature in its prime,
 a *
 @ Meese ok wt
 sees : t
 i Dttame@ mec!
 BP paving!
 seb
 \. a
 ~ rene SV Ray sage On
 ~ ee
 a W-TAR
 “ttl RICH NATURAL FLAVOR
 Prime.
 Nature's low tar cigarette.
 $ ~ 0.2 mg, euconna, av. per tiqarente, FIC Method.
 Warning: The Surgeon General Has Determined
 That Cigarette Smoking Is Dangerous to You Health,
 670598048
 PRODUCED FROM BéW WEB SITE
 ‘8b086S029
 Vey A nt by </doc>


[User] <|image|>Detect words in the photograph.

[Assistant]
<doc> HEAD-ON TEST OF
 TWO 84 MM FILTER CIGARETTE
 #927 VS, #957
 #967 VS, #937 /
 A Report to the Brown & Williamson Tobacco Corporation
 Prepared By:
 Market Facts, Inc.
 100 South Wacker Drive
 Chicago, Mlinois 40406
 February, 1978
 HBr 4
 J516
 1976-220CM
 SSOSECOLS </doc>


[User] <|image|>Identify text in the picture

[Assistant]
<doc> From: McAlpin, Loreen
 Sent: Monday, May 03, 1999 9:08 AM
 To: Akimoto, Yoko; Amador, Jennifer; Badstuber, André; Bugg, Joy J.; Carchman,
 Richard; Church, Cynthia S.; Davies, Bruce D.; Dempsey, Ruth; Dunaway, Debby;
 Ellis, Cathy; Goldsmith, Alan |.; Gullotta, Frank P.; Gygax, Jill; Haussmann, Hans;
 Hirnikel, Daniel J.; King, Valerie A.; Kinser, Robin D.; Koller, Debbie; Larson, Lynn E.;
 Lau, Raymond; Leyden, Donald; Lipowicz, Peter J.; Mawyer, Denise T.; Mitchell,
 Kathy A. (Research Center); Reif, Helmut; Ritter, Mitchell; Sanders, Edward; Schorp,
 Matthias; Seeman, Jeff; Takada, Kohji; To, Debra; Tricker, Anthony; 1-14-00Walk,
 Roger; Zhang, Mingda
 Subject: FW:ETS Study
 Importance: — High
 BYE AL
 2078584578 </doc>


[User] <|image|>Parse text from imagery.

[Assistant]
<doc> RECEIVED
 8501 OCT 2 199)
 -HAMISéd MAXWELL!
 Ls we ee, ~ 3
 PHILIP MORRIS USA
 RESEARCH AND DEVELOPMENT DEPARTMENT
 PHILIPPINE TEST #402
 PM1-01QP
 MR2-01QP
 MR6-01QP
 PM6m-01QP
 PM8m-01QP
 DISTRIBUTION!
 Mr. W. I. Campbell Mr. W. G. Longest
 Mr. P. J. Clarke Mr. F. A. Lowman
 Mr. D. Devitre ' Mr. H. Maxwell
 Mr. H. Ganteaume Mr. J. L. Myracle
 Ms. M. Jaquith ° Mr. L. Pollak
 Mr. W. G. Lloyd Mr. F. E. Resnik
 Mr. A. G. Logan Mr. W. Snelling
 Mr. L. F.Wong
 PREPARED BY: Coch. 8
 7, "Dp. nN
 CC Dicolt- :
 : Gud
 ) ¥
 APPROVED BY: \Weduchl 6
 (} nN
 DATE: September 30, 1981 </doc>


[User]
<|image|>Read the following text: <doc> CURRICULUM VITAE
 Name: Yong Q. Chen, Ph.D. Position: Assistant Professor
 Office Address: Home Address:
 9207 Scott Hall, Department of Pathology 20624 Lochmoor
 Wayne State University Harper Woods, MI 48225
 540 E. Canfield Ave. Phone: (313) 882-4130
 Avalosse, B., Chen, Y. Q., and Rommelaere, J. Brit. J. Cancer 54, 356-357, 1986.
 Chen, Y. Q., deForesta, F., Hertoghs, J., Avalosse, B., Cornelis, J. J., Rommelaere, J. Selective Killing of
 simian virus 40-transformed human fibroblasts by parvovirus H-1. Cancer Res. 46, 3574-3579, 1986.
 Hilgers, G., Chen, Y. Q., Cornelis, J., Rommelaere, J. Deficient expression of enhanced reactivation of
 parvovirus H-1 in ataxia telangiectasia cell irradiated with x-rays or UV light. Carcinogenesis. 8, 315-
 319, 1987.

[Assistant]
 Chen, Y. Q., Tuynder, M., Cornelis, J., Boukamp, P., Fusenig, N. E. and Rommeleare, J. Sensitization of
 human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but
 does not require them to be tumorigenic. Carcinogenesis 10, 163-167, 1989.
 Hilgers, G., Abrahams, P. J., Chen, Y. Q., Schouten, R., Cornelis, J. J. Van der EB, A. J., Rommelaere, J.,
 Impaired recovery and mutagenic SOS-like responses in ataxia telangiectasia cells. Mutagenesis. 4,
 271-276, 1989.
 Avalosse, B. L., Barrijal, S., Chen Y. Q., Cassiman, J. J. and Rommelaere, J. Identification of a
 transformation-sensitive nuclear protein from normal human fibroblasts. That specifically interacts
 with minute virus of mice and correlates with cell resistance to the parvovirus. Molecular
 Carcinogenesis, 2:245-251, 1989.
 Cornelis, J. J., Chen, Y. Q., Spruyt, N., Duponchel, N., Cotmore, S., Tattersall, P., Rommelaere, J.
 Differential susceptibility of human cells to the killing by autonomous parvoviruses MVM and H-1 is
 regulated at the transcriptional level. J. Virology 64: 2537-2544, 1990.
 Chang, Y.S., ¥.Q. Chen, L.A. Fitzgerald, K.V. Honn. Analysis of integrin mRNA in human and rodent
 tumor cells. Biochem. Biophys. Res. Commun. 176:108-113, 1991.
 Chopra, H., J. Timar, Y. Q, Chen, X. Rong, I. M. Grossi, L. A. Fitzgerald, J. D. Taylor, K. V. Honn. The
 lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of
 integrin appz on melanoma cells. Int. J. Cancer 49: 774-786, 1991. </doc>


[User] <|image|>Read the following text: <doc> 96168741

[Assistant]
 TVOOT
 -v66l |
 MATAYAAO AULLSNGNI </doc>


[User]
<|image|>Continue reading the text: <doc> CABARRUS COUNTY , EFFECTIVE DATE: 12/12/94
 MERIT ULTIMA 100 REGULAR SP STANDARD PRODUCTION
 BRAND CODE-02890 (STD)
 TOBACCO ROD LENGTH : 68.0 MM
 TIPPING LENGTH : 36.000 MM
 CIGARETTE: PAPER WIDTH ;: 27.00 MM
 CIRCUMFERENCE : 24.80 MM
 CALCULATED VOLUME : 3,328... 1463 CUBIC: MM
 CALCULATED DENSITY : 17.6782 CGMS/CC
 TARGETS
 PACK 0. V. . : 12.00 % W/W
 FIRMNESS: TARGET: : 3.30 MM
 RANGE 3 FROM 2.90 TO 3.70: MM (ONE WEEK N=3)
 RANGE : FROM 3.20 TO 3.40: MM

[Assistant]
(EIGHT WEEK, N=24)
 FILLER WEIGHT | : - 5883564 GRAMS
 CALCULATED WEIGHT: 1.2971 LBS. /1000
 PAPER AND AOHES!VE $ -0523827 GRAMS
 ROO WEIGHT : - 6407391: GRAMS
 TIPPING AND ADHESIVE 3 0495762 GRAMS
 TOTAL LESS PLUG : -6903.153: GRAMS
 REASON FOR CHANGE : FIRMNESS TARGETS AND/OR: RANGES. ADDED
 . : NO OTHER CHANGES : 9031294733
 PREPARED BY : J.D. ELLIS / (AS400) PRINTING DATE : 12/01/94
 PREPARATION DATE : 12/01/94 PRINTING TIME 2 13:54:34
 APPROVED BY: Choucs iy} Ato SUPERCEDES. SPECIFICATION DATED: 10/18/93 </doc>


[User]
<|image|>Parse the text behind: <doc> Date: October 14, 1998 State. X Local: (J
 RECIPIENT INFORMATION
 Name Michael Olguin
 (individual Candidate or Fundraising Org.)
 Address 325 Springs Street
 Socorro, NM 87801
 Current Office and District House #49
 Aspired Office and District
 Party Democrat
 Leadership Position
 Committees
 (Note Chairmanships)
 Amount $500.00
 Account Code 1401-7710-NM-01
 Check Payable to Committee to Re-Elect Representative
 Michael Olguin
 Address
 (Only if different from address above)
 Notes:
 As soon

[Assistant]
as possible
 Approved by:
 Revised 2/95
 KL Wess
 (Regional Vice Fresident’s signature)
 TI1712-0560 </doc>


[User] <|image|>what is written in the image?

[Assistant]
<doc> From: Darnall, Stacy L.
 To: Barbara Goho; Ben Ruffin; Brenda Matthews; Carol Makovich; Carole Crosslin;
 Charles Blixt; Dan Donahue; Deborah Bratton; Delise LeBlanc; Denny Jr, Damell;
 Duchesne, Steve; Ellen Merritt, Gerard Manganti; Glenda Evans; Huntley Whitacre; Jan
 Fulton Smith; Jason Wright; Joan Dalton; John Fish; John Singleton; Judy Dobbs;
 Katherine Michalek; Maria Sceppaguercio; Mark Holton; Maura Payne; Murray Joncs;
 Phyllis Rumple; Roger Mozingo; Seth Moskowitz; Sheryl Spainhour; Teresa Wood:
 Thomas McKim; Tommy Payne
 ce:
 BCC:
 Primary Date: 4/20/1999 3:15:27 PM
 Last Modified Date: 1999-Apr-21 12:07:42
 Last Touched Date:
 Sent Date: 1999-Apr-20 15:15:27
 Received Date: 1999-Apr-20 15:15:27
 Subject: Release 99-08
 Attachments:
 99-08 doc
 The attached has been forwarded to PR Newswire for distribution.
 70050 2140
 e68l 6escs </doc>


[User]
<|image|>Read the following text: <doc> ~ Somuch flavor
 no picture could -
 O it justice.
 Instead of eye-catching photography, we offer you
 some eye-opening facts. Thanks to Enriched Flavor™
 delivers real, satisfying taste, with even less tar than other leading lights. In fact,
 a nationwide test shows astes just as good as cigarettes with up
 to 38% more tar. So it you want pictures, this ad

[Assistant]
may be lacking
 something. But if you want flavor, it’s got everything.
 Enriched Flavor,"low tar. 4 solution with
 SURGEON GENERAL'S WARNING: Smoking | cen bong
 By Pregnant Women May Result in Fetal _ Bte833
 SP stin Morris Inge Tune
 Injury, Premature Birth, And Low Birth Weight.
 Kings 8 mg ‘tar,’ 0.6 mg nicotine av oer cigarette by FTC method
 TESIIISTVG </doc>


[User] <|image|>list the words in the image.

[Assistant]
<doc> Attachment C
 Responsible Retailer Program
 Commonly asked questions from Retailers and Answers
 What does “comply with the elements of the We Card program mean/What are my
 responsibilities?
 You need to demonstrate that you responsibly sell tobacco products and that you comply with your state law.
 You need to post a sign that communicates to your customers the minimum age law. This sign can be from the
 state, where available, or from the We Card program, or any other responsible tobacco retailing program. And,
 you need to sign a Philip Morris pledge card, that we will soon provide you, with indicating your intention to
 uphold the law and incorporate "We Card" or similar elements in your sales practices. If your state requires that a
 specific sign be posted, you need to post the state required sign. And, if you suspect that a customer is a minor,
 you need to ask for identification. If you are not convinced that the I.D. is valid and/or that the purchaser is of
 proper age, you should not make the sale.
 Do I have to use the We Card program signage?
 No. Any comparable minimum-age signage is acceptable. We Card, however, is an educational program that
 includes tools to help you train your employees to uphold the law and so, we hope that you will use ALL of the
 materials in the We Card program that go beyond the customer signage.
 How can I get a copy of the We Card program?
 If you are a member of a national retail trade association (NACS, FMI, NGA, etc.) you will receive We Card
 program information and an order form from them shortly, so you can order a We Card program kit. If not, we
 will be in touch with you shortly with details about ordering the We Card program kit.
 How will PM confirm compliance?
 During normal and customary in-store sales calls, PM will confirm that minimum-age signage is posted in your
 store. PM will rely on appropriate enforcement authorities in your state to advise whether you have been fined or
 convicted of selling tobacco products to minors.
 When you withhold merchandising benefits, do you mean money or promotions, and for how
 long?
 All in-store promotions and promotion payments, plus where applicable, flex funds are withheld and/or
 suspended. Failure to comply with the elements of the We Card program will result in a one month suspension
 of Philip Morris USA merchandising benefits upon a fine or conviction for selling cigarettes to a minor. A first
 offense will be waived for those who do participate in the program. However, the Retailer loses its eligibility for
 the Responsible Retailer Fund.
 If Philip Morris USA is subsequently notified by enforcement authorities of additional fines or convictions of the
 store, a one month suspension of merchandising benefits will be imposed for each such additional fine or
 conviction. If a store is fined or convicted three times within twelve months following a fine or conviction for
 which merchandising benefits were suspended, Philip Morris USA will suspend the store’s merchandising
 benefits for four months from the date of this third fine or conviction.
 Following a four month suspension, if a store is fined or convicted for the sale of cigarettes to minors, no waiver
 will apply and a one-month suspension of merchandising benefits will be imposed for each fine or conviction. If
 the store is fined or convicted three times within a twelve month period commencing after a four month
 suspension of benefits, Philip Morris USA will again suspend the store’s merchandising benefits for four months
 from the date of the third fine or conviction.
 2062894901 </doc>


[User]
<|image|>Parse the text behind: <doc> 52115 0167
 VIEWER DISCRETION

[Assistant] ADVISED </doc>


[User] <|image|>Retrieve written information from the image.

[Assistant]
<doc> | ONINVAW JO HOUVIS NI |
 eee
 sorcerer net) </doc>


[User] <|image|>Translate text in the picture.

[Assistant]
<doc> . + oe , %
 a - \fl-Cltles Office COMM-TRONICS OF VA. INC. Richmond Office f
 103 Chesterfleld Ave. COMMUNICATIONS SPECIALIST 7401 Jefferson Davis Hwy. :
 Ettrick, VA 23803 PRE OTE Richmond, VA 23237
 (804) 526-5250 moronota |. Specializing In: .. "one ota (804) 275-6970
 zway RaDio #
 AUTHORIZES CEALER fag
 (804) 796-3017 COMMUNICATIONS 2-Way Communications "
 (804) 748-7284
 Service, Sales, and Contracts
 a 785 -
 OuT
 SIDE
 OATE
 ot CALLING
 neo TECH
 * WORK DESCRIPTION
 te PIL OD2
 TSW OlS
 _ TIME
 4, 10,00
 iat 1A ge
 /4 fi
 Time nO
 CUSTOMER
 Di) Q
 ADOMESS
 Civy SYATE Ze
 MA |/1A/| Tam] “te | swa J205
 # ~~
 Be (2 Fy
 EQUIP
 Loc
 accT
 SERIALS
 MOOEL 8
 UNIT &
 COMPLAINT
 SPECIAL INSTRUCTIONS
 DO +
 PART NUMBER DESCRIPTION
 NOTIFIED
 NAME
 COMPLETION OATE
 FREQUENCY (mHz)
 " 6% BIS
 2 YLA BIS
 "YEU, Foe
 BATT | ANT | CASE
 SPKR | MIC | C.H.
 ov Ly) x Stns 3
 POWER
 ner
 Ad Pwo
 F4 dg 7006 as CaP CODE
 recnpie Ee
 INTEROFFICE
 MATERIAL
 TAX
 a EOS
 FE FEY,
 LABOR
 THE ABOVE COMPLAINT HAS BEEN COR-’
 RECTED AND THE UNIT [S OPERATING TO
 MY SATISFACTION, | CERTIFY THAT | HAVE,
 A VALID FOC LICENSE.
 LULIICS ot pen /2 FO
 CUSTOMER Los te DATE
 MILEAGE
 SHIPPING
 TOTAL </doc>


[User] <|image|>Retrieve written information from the image.

[Assistant]
<doc> COPY
 CHART NO, __
 NAME, a. DATE.
 SEX; Male Female.
 RACE; Whites Colored. latin American, Other,
 AGE: 15-19 20-24 25-29 30-39 OmL 9
 50-59, 60-69, 70-79, 80-89, 90¢
 i, Do you now smoke? Cigarettes, Pipe. Cigars.
 1 2, How many cigarettes do you now smoke dally?
 More than 20_ 20, 10. 5 or less_____
 3. Do you-now inhale cigarette smoke? Alwaye___ Frequently, Rarely___
 | =
 4, How many cigars do you now smoke daily? 7 or more. 3-6 PL
 : 5. How much pipe tobacco do you now use every day?
 10 pipefuls_ 6-9 pipefuls__.. «5 or less pipefuls
 6, How many years have you been smoking? eee ee
 7, How many years have you been smoking the amount given above?,
 8, Did you ever smoke? Cigarettes__ Pipe, Cigars
 9, How much? Rarely Occasionally. Frequently,
 10, How many years did you smoke?,
 il, How many since you stopped smoking?, ne
 Do you consider this interview satisfactory? If not, why?
 interviewer </doc>


[User] <|image|>what texts are in the picture?

[Assistant]
<doc> ELIZABETHTON, TN.
 STAR
 D. 6,118 — S. 7,770
 BRISTOL METROPOLITAN AREA
 fug 21980
 wig 7 CBSA
 Best Way To
 Quit: Quit!
 Most’ confirmed cigarette
 smokers who decide to quit the
 habit find it hard to do so.
 There are chemical and psy-
 chological reasons for this,
 and the withdrawal symptoms
 are no joke. One important
 question for those who want to
 quit smoking, then, is how to
 manage this with the least pos-
 sible withdrawal problem —
 _ and the best chance of kicking
 the habit permanently.
 Research done by Univer-
 sity of California - Los Angeles
 psychologists sheds new light
 on the matter. Saul Shiffman
 with a group of smokers who
 sought to stop over a two -
 week period. Half of the
 study’s subjects tried to grad-
 ually phase out the habit; the
 others quit “cold turkey’.
 SM < ” Bey get a
 A ba lbete. Cade
 ‘. \ ait } (Caanriis
 “ 4
 When the returns were in, the
 cold turkey group clearly won
 out. |
 Both groups’ reported
 similar symptoms at first —
 craving for tobacco, weight
 gain, irritability. But the
 among the smokers who simp-
 ly quit, while they persisted in
 the phasing - out group. The
 eonclusion of Shiffman and
 Jarvik: “The cigarettes in-
 dulged in by smokers who at-
 tempt to cut down may serve
 only to prolong their agony by
 intermittently reinforcing
 smoking.” |
 To clinch it, the report tells.
 us that a gradual phaseout
 merely “precipitates a chronic
 state of withdrawal.” So the
 counsel to smokers bent on be-
 Though it won’t be easy, this
 course may turn out to be
 and more effective. _
 An A,
 teak aless
 Ey as o
 HEME cae Lk </doc>


[User] <|image|>Recognize text in the image.

[Assistant]
<doc> From: Laufer, David on Tue, Mar 11, 1997 5:08 PM
 Subject: RE: IN Medicaid poll
 To: Fisher, Scott; Little, Greg; Turner, Henry; Woodward, Ellis
 Cc: Cohen, Neal
 Henry has some good questions from FL
 Er67v2SS202 </doc>


[User] <|image|>Decode text from the snapshot.

[Assistant]
<doc> Mr.
 II.
 /gof
 IV.
 RE:
 L-3843B °
 Grade
 $02C
 HSC
 SBT
 FBP1
 FT5
 BSM
 LB3
 G-5 (rolled and cut)
 C-1
 F-1
 B-3
 B-9
 Cane Sugar
 G-5 stem (gms./kg. of stem)
 C-1
 F-1
 B-3
 B-9
 Cane Sugar
 Rod
 1. Size (mm)
 2. Length (mm)
 3. Paper
 Filter
 1. Size (mm)
 2. Length (mm)
 3. Type
 4. Plasticizer
 5. Tipping
 6. Tipping Length (mm)
 7. Plug Wrap
 Cuts Per Inch
 PRR
 WUUnNIorruMmOoOnt ©
 ooooooo°oo
 aay
 100.0
 25.0
 65.0
 556
 24.65
 15.0
 3.3/42,000
 FF-~4 Triacetin
 Cork
 19.0
 922
 SL6Z@ POTTS </doc>


[User]
<|image|>Parse the text behind: <doc> : 2 So 19 1 ewe MAIL
 ws My AESISTEN | : :
 ee 397
 Cl IC. conga RESEARCH CENTER | BVBAIBP..L. .
 Business haminietration * , eo -_ 2 8 1932 Zaventern * ~ ~
 weap Toliaarvavenue du Poage 10%. ”
 - Geadiesscordesadronese: # “ we
 TKLKFAX (fak nr.t 02/ 726 03 69) 2 Falotoondt bibpnone: 02-720 55 94
 ae t éiétax: 02-725. 12 09 :
 Sandv: Lk Belgid Is: ~ Telofe o
 t.a.v. Dhr.. Eggermont : a Pos
 Leuvensesteenweg 1188 ed we ee
 0 , . ° ° _gGB/MgV re oe
 ‘B-1930 Zayentem / , {datpe 00626355000.
 Bestelling Nr. {Commande No.: 1333/93 | _ 7 Datun/Date: 16 sep.93
 (geiieve deze Tefeste in level gevel ap de taptuur te ne 4 Oe
 veusnes wand sxception reprenare. cette rétérence our te factwe) . Fe . a
 ‘ “ ‘wu b eiten ‘pan de‘op keerzijae vermeice sancoopwoorwessden - we ». ' - : :
 . Nous commandons geion les conditions dsochal imprimée au verses . * . . .
 . : hye * o .
 - ‘POSITIE HOEVEELHEID EENHEID AATIKELOMSCHANVING PRUS —
 POSITION QUANTITE ~ UNITE DESIGNATION O’ARTICLE oa ww
 oy 6. meter RVS puis, diam. @ um x 1. Sy ce —
 . kwaliteit 304 \ .
 * . . aan BF 164,-/meter — . 984,-:
 2 6. meter RVS buis, diam 6 mm x ), oe
 .

[Assistant]
kwaliteit. 304 | ce, goog ete”
 aan BF 112,-/meter , 262s.
 . . . . j . . 8tf
 . “TOTAAL: = 1.656,-
 0 “SMa atapneppeiike zetol: Zaventem, Belg
 : gE Ze | joa
 ahs “Managenent, neeo
 pies Cee
 436 088 ad “ </doc>


[User] <|image|>list the words in the image.

[Assistant]
<doc> sain ne
 Born:
 1972
 1972+ 73
 1973-74
 1974-
 1974-
 CURRICULUM VITAE
 CARLTON McCARTHY
 May 2, 1950 Boston, Massachusetts
 B.S. in Biology, Boston College, Chestnut Hill, Massachusetts
 Research Assistant, Division of Respiratory Diseases,
 Channing and Thorndike Memorial Laboratories, Harvard
 Medical Unit, Boston City Hospital, Boston, Massachusetts
 Laboratory Supervisor, Division of Respiratory Diseases,
 Channing and Thorndike Memorial Laboratories, Harvard
 Medical Unit, Boston City Hospital, Boston, Massachusetts
 Laboratory Supervisor, Division of Respiratory Diseases,
 Harvard Medical Unit, Beth Israel Hospital, Boston,
 Massachusetts
 Research Associate, Division of Respiratory Diseases,
 Harvard Medical Unit, Beth Israel Hospital, Boston,
 Massachusetts :
 American Federation for Clinical Research
 11300142 </doc>


[User]
<|image|>Read the following text: <doc> "> IVE SMOKED _~
 CAMELS FOR
 _ 2OYEARS.
 “FOR My FASTE AND __
 FOR MY THROAT, _,
 CAMELS SUIT ME
 TOA Ty’
 - In the vital Buttle of farm production, «
 formar is a réal fighting tian! And, like the men >
 élgarerte is apt to be: Camel, too
 “7 CAN sure understand why Camels are Bot choice with
 +4. menin the service,” says Former “Met” Metcalf
 hown ; “Pye

[Assistant]
smoked Camels for 20 years, arid
 ‘there's nothing like “em for steady pleadure. ‘The flaver® *
 - is rich and full, and C Js are extra mild -—always oo
 ‘amiooth, cool, and easy:
 HET.
 here vigarz </doc>


[User]
<|image|>Parse the text behind: <doc> “1360 Avenue of the Aner}
 New York, NY. [O09 . . » fe
 (212) 765-7674 November, 1979
 Q.5
 Q.6
 Fok No. 79102
 argent
 CIGARETTE MARKET OPPORTINITY STUDY.
 we Je
 ga Mal IHPORTANT . }
 - A THES QUESTIONNAIRE IS NOT TO BE ACMINISTERED 1
 TO_ANYOVE UNDER 21 YEARS OF AGE
 Hella, my name is from Norsearch, 2 national narket-reseavch
 Firm,” We are conluckTig’® Survey in this area anong cigarette smokers
 21 years of aye or older,
 Nay I speak to a male smoker who is 21 years of age or o'der?
 ES, 1--REPEAT INTRODUCTION IF HECESSARY AND GO 1 2.3
 NOMAIE SMOKFR 2--ASK 1.2
 UNAVAILABLE 3--DETERMINE BEST TINE TO CALL BACK & RECORD TINE BELOW.
 Is there 4 Female aged 21 or older at home who smokes cigarettes?
 YES de-ASK TO_SPEAK UITH SHOKER, REPEAT INTRODUCTION,
 ASK 0.2
 NO 2--TERNINATE f
 UNAVAILABLE 3--DETERMINE BEST TIME 70 ALL BACK & RECORD BELO,
 SALLBACK 2
 Dp you or does anyone in ycur household work for an advertising agency,
 market research conpany cr tobacco company?
 Yes 1 TERMINATE
 nO. 2--ASK Q.4
 About how many cigarettes a day would you say you smoke?
 5 ar Tess 1 THANK RESPONDENT & TERMINATE
 Hore than 5 2 = CONTINUE WITH Q.5
 Is the brand of cigarette you smoke most often a

[Assistant]
menthol or non-menthot kind?
 Ner.thol 1--THANK RESPONDENT & TERAINATE
 Korenenthol — 2-=CONTINUE WITH 2.6
 Is the size of fegeee you smoke most oftan king size, extra Tong 100's
 or 120"
 tes oy
 eee HE RESPONDENT & TERNINATE
 1ze Speriwe win Q.7
 366ES27025 </doc>


[User]
<|image|>Read the following text: <doc> -56 feed /. (8:72 os
 bijy 9 13-74 .
 | ©1281 mceoery Tomsed 60
 To smoke
 or not to smoke.
 That is the question.
 With all the slings and arrows that have been aimed at smoking, you
 | may well be wondering why you smoke at all.
 If you don’t smoke nobody is urging you to start.
 But if you do smoke, you may enjoy it so much you don’t want to stop.
 There's the rub. Because if you do smoke, what do you smoke?
 The cigarettes of the past provided a lot of smoking pleasure but they —
 also delivered a lot of the ‘tar’ and nicotine the critics have aimed at.
 And most of the new wave brands with low ‘tar’ and nicotine
 taste like a lot of hot air.
 But now Vantage has entered the scene.
 Vantage is the cigarette that succeeds in cutting
 down'tar’and nicotine without compromising flavor.
 While Vantage isn’t the lowest'tar’and nicotine
 cigarette you'll find, it certainly is the lowest
 one you'll enjoy smoking. 1
 If you smoke, ty a pack of Vantage.
 And if you don’t, why not show this ad
 to someone who does.
 It might settle the question.
 MENTHOL
 lit
 0; Bice
 O77:
 nicotine
 Warning: The Surgeon General Has Determined
 That Cigarette Smoking Is Dangerous to Your Health.
 i gis hang Fier, 1 mg.‘ta”,07 mg nicatine, Mental. 11 mg “ta, 0.8 mg. nicotine,

[Assistant]
av. pe cigarette F1C Report OCT, 74,
 2 aus 8/97
 Lies «ae ad
 ADVERTISING PREPARED BY LEBER KATZ PARTNERS
 JOBNG ALOL49 .
 CLIENT: VANTAGE FILTER
 MEDIA: NEWSPAPERS-800LINES
 | DATE: JANUARY 20, 1975 Sas
 COPY NAME “TO SMOKE OR NOT TO SWORE."
 O9kzZ L9zos .. </doc>


[User] <|image|>Detect words in the photograph.

[Assistant]
<doc> PROJECT NAME: ART 85mm SP (4mg FTC Tar)
 FILTER MANUFACTURING SPECIFICATION - Ad Pack M73
 FINISHED FILTER ROD DESCRIPTION
 Machine Type _KDF2
 Filter Rod Length 108 mm
 Filter Circumference 24,45: mm
 Number Up 4
 Plug Length 27.0 mm
 Rod RTD 533.40: mm H,0
 Plug RTD 133.35: mm H,0
 Plasticizer TA
 Application Percent 7.00
 Application Weight 5.09 grams/100: rods
 PM Material Code 05-800-A
 Filter Tow
 PM Material Code 05-222-E/C
 Plug Wrap 6
 PM Material Code
 Anchor Adhesive
 Number of Anchor
 PM Material Code
 Upaco_ 6732-0:
 61-425-A
 Lap Adhesive Fuller HM 8229CH
 PM Material Code 61-428-A
 Dry Weight 72.68 gms/100 rods
 Dry Weight with Glue 72.92 gms/100 rods
 Wet Weight with Glue 78.01 gms/100 rods
 <66S0TEzZOe </doc>


[User]
<|image|>Continue reading the text: <doc> Principal investigator/Program Director (Last, first, middie): GARRARD, WILLIAM T.
 BIOGRAPHICAL SKETCH
 Give the following information for the key personnel and consultants and collaborators. Begin with the principal
 investigator/program director. Photocopy this page for each person.
 NAME POSITION TITLE
 Julia George Research Fellow
 EDUCATION (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
 YEAR
 INSTITUTION AND LOCATION DEGREE CONFERRED FIELD OF STUDY
 Dartmouth College, Hanover, NH A.B. 1985 Biology
 University of Michigan, Ann Arbor, MI Ph.D. 1991 Microbiology/
 Immunology
 Professional Experience:
 9/85 - 8/87 NIH Genetics Training Grant Trainee
 University of Michigan Medical School
 Department of Microbiology and Immunology
 8/87-10/91 Graduate Student Research Assistant
 University of Michigan Medical School
 Department of Microbiology and Immunology
 11/91-12/91 Post-Doctoral Research Fellow
 University of Michigan Medical School
 Department of Microbiology and Immunology
 1/92- present — Post-Doctoral Research Fellow
 University of Texas Southwestern Medical Center
 Dallas, TX
 Selected Publications
 George, J., Penner, S.J., Weber, J.S., Berry, J.B. and Claflin, J.L.

[Assistant]
(1993) Influences of membrane
 immunoglobulin density and affinity on B-cell signalling by antigen. Journal of Immunology 151(11): 5955-
 5965.
 George, J., Sheehan, K.M., Brodeur, P.H., and Claflin, J.L. (1993) Junctional Diversification in the
 Generation of the Precursor of a Discrete Immune Response. Molecular Immunology 30 (4): 395-402.
 Kenny, J.J., Moratz, C.M., Guelde, G. O'Donnell, C.D., George, J., Dell, D., Penner, S.J.,Weber, iS.,
 Berry, J., Claflin, J.L. and Longo, D.L. (1992) Antigen binding and idiotype analysis of antibodies obtained
 after clectroporation of heavy and light chain genes encoding phosphocholine-specific antibodies: A model for
 T15 idiotype dominance. Journal of Immunology 176 (6): 1637-1647.
 George, J. and Claflin, JL. (1992) Selection of B Cell Clones and Memory B Cells. Seminars in
 Immunology 4 (1): 11-17.
 Claflin, J.L., George, J., Dell, C.L. and Berry, J.B. (1989) Patterns of Mutations and Selection in Antibodies
 to the Phosphocholine-Specific Determinant in Proteus morganii. Journal of Immunology 143(9): 3054-3063.
 PHS 398 (Rev. 9/91) Page
 Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b. </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> 1808 BENSON & HEDGES LTS 100 MVF MFG: PM (1) APR 25, 1988 PAGE 1
 COMMENTS: SMOKE MENTHOL RESULTS REMOVED. INCORRECT ANALYTICAL DATA FOR MAY 19
 CONFIDENTIAL 1986 NOV87 1987
 PHYSICAL TEST VARIABLES
 WEIGHT:
 IND CIG WI (GM) 1.1253 1.1244 1.120
 NET TOB WEIGHT (GM) “- =~ --
 DENSITY (GM/cc) -~ -- --
 DRAFT:
 CIG DRAFT (MM) 128. . 129. 127.
 CIG DRAFT SD (MM) 7.4 6.5 6.4
 DELTA P (MM) ho. 39. hi.
 DELTA P SD (MM) -- -- --
 DRAFT W/O DIL (MM) 168. 168. 168.
 DRAFT W/O DIL SD(MM) 7.9 6.6 7.3
 FILT SEG DRAFT (MM) 111. 107. 107.
 TOB ROD DRAFT (MM) 58, 61. 61.
 AIR DILUTION-% 29.9 29.4 30.9
 FIRMNESS:
 CIG FIRMNESS (.1MM) 7.74 . 7.84 7.85
 CIG FIRMNESS SD 1.14 1.36 1.32
 FILT FIRMNESS(.1MM) 6.94 7.29 7-11
 SIZE: .
 CIG SIZE (MM) 24.87 24.97 24.90
 CIG SIZE SD .07 .07 .07
 LENGTH:
 CIG LENGTH (MM) 99.61 99.14 99.04
 MOISTURE:
 PACK MOISTURE-% 11.97 11.82 11.76
 PAPER:
 WIDTH (MM) -- -- --
 POROSITY (CORESTA) 37.9 56.8 Lg
 OvOE O890SG </doc>


[User] <|image|>Detect words in the photograph.

[Assistant]
<doc> QUESTIONS TO HENNINGFIELD
 (DeNOBLE NICOTINE. PAPER)
 Q: Dr. Henningfield, when you appeared before us last month, you
 indicated that you believed that Dr. De Noble’s unpublished paper entitled
 Nicotine As A Positive Reinforcer for Rats: Effects of Infusion Dose and Fixed Ratio
 Size was a significant advance beyond the other literature available at that time. In
 fact, however, even before Dr. De Noble’s work, there had been a number of
 published studies which demonstrated that nicotine was a positive reinforcer in
 other animals such as monkeys and dogs. Correct?
 99S9IeeOzOe </doc>


[User] <|image|>Read written language in the visuals

[Assistant]
<doc> ‘Textual Database Management
 at the
 Philip Morris Research Center
 Gail D. Davis & Alice Lewis
 September 1995
 Good Morning(Afternoon)
 My talk today will highlight a 2 year conversion effort for our textual
 database applications to newer technology. | will talk about why a
 conversion effort was necessary and describe in detail the products that
 we are using today for management of this information. We are using
 Sybase ® as our relational product and Topic ® as the full text retrieval
 product. There are other commercially available products in both these
 areas which might also be used.
 egerraLoe </doc>


[User] <|image|>Parse text from imagery.

[Assistant]
<doc> 9938/990317
 MEAN SCORES
 | 425
 sham |!
 IR4F
 IROF
 2505304923 </doc>


[User]
<|image|>Continue reading the text: <doc> BIOGRAPHICAL SKETCH
 Give the following information for key professional personnel listed on page 2, beginning with the
 _ Principal tnvestigator/Program Director. Photocopy this page for each person.
 NAME
 TITLE SIRTHDATE (Mo., Day, ¥r.}
 of Immunology
 EDUCATION — !
 INSTITUTION AND LOCATION oa eoeeer CONFERRED FIELD OF STUDY
 Antioch College, Yellow Springs, OH left after 3 yrs. without degree
 to beginj graduate work
 University of Chicago, Chicago, IL M.S. 1964 Microbiology
 Yale University, New Haven, Ct Ph.D. 1969 Immunology
 1969
 Postdoctoral Fellow, Yale University, Dept. of Pathology (R.K. Gershon)
 Immunology, Duke University Medical Center
 1975
 Visiting Scientist, University of Alberta, Department of Immunology
 (with BE. Diener, June-August)
 Australia, (with G.J.V, Nossal), Eleanor Roosevelt Fellowship
 1981
 1983
 Visiting Scientist, Scripps Clinic & Research Foundation, La Jolla, CA
 (with N. Klinman, June-July)
 Visiting Scientist, Basel Institute for Immunology, Switzerland
 (with C. Paige, June-August)
 1986
 and Professor of Microbiology, University of Rochester, Rochester, NY
 Visiting Scientist, National Institute for Medical Research, London, UK
 (with G.G.B. Klaus, 5/86-12/86) Eleanor Roosevelt Fellowship
 1988
 NIAID, NIH
 Jane Coffin Childs Postdoctoral Trainee, Oxford, England (1969)
 Research Career Development Awardee, NIH (1975)
 Eleanor Roosevelt Fellow, International Union Against Cancer (1976-77)
 Dean's Professor of Immunology, University of Rochester Medical Ctr. (1983-)
 Eleanor Roosevelt Fellow, International Union Against Cancer (1986)
 American Association of Immunologists (1973)

[Assistant]
 American Society for Experimental Pathology (1974)
 Education Committee, AAI, 1980-85; Chairman, 1981-84
 FASEB Education Committee, 1981-; Chairman, 1987-
 WIS Education Committee, 1986-
 Study Section Member, Experimental Therapeutics, NIH, 1982
 American Cancer Society Advisory Committee, Immunol. & Immunotherapy, 1982-
 86, Vice-chairman, 1984, Chairman, 1985-86. </doc>


[User]
<|image|>Continue reading the text: <doc> Date 247/57
 Cigace: e. da forma tian
 Cgaceile Leng th- Simm
 kena th Soaked - SOmm _ -
 Back - (Sinem Cnbbadal Silica 820 ormod ttn of eigtnalde nah
 “Tube e1yg9-3! prwhrnbod wth Cbbaiddll Sicn 93d
 | Tube Size - 120
 Cochon= 90% Kaorb /10% Koll. damtham Husene
 Cachan Size- 222 Melding
 | Macket. Cplile Seo ow cme
 | Vache t Size- 3on Modding
 Overmeag - PSNZ-ISX- 3
 | Shaw Size 1 Simon Pale dusee im {Den ud 55
 Substrate - ase m9. QQ rey 3-3 107

[Assistant]
 Sol ing, “Ten Farcmaion
 Second tigh- fui «| Second ut - A573
 Ficst ia}. - 4 440s “34 Firat wah - 34.1320
 4 ad
 F wyeEM- 002 & wTPM- 0009
 - | ; = 7
 Tube tug t DO De J oufFs + | cleacing puff =? auf
 Pod Wp b. = 10203
 “Tota | WwPmM- 0224 Eee Ang
 Qo —_
 00-08, Tnfor mation we
 — +> Sample 2 CO 10.2505442521 mq COP 24. 240199874 mg oT OF
 sample 2 CO 10.19m009622 mq Coz ~
 25.8556160011 mg </doc>


[User]
<|image|>Parse the text behind: <doc> - vo ~ot*? 7089
 | 9°2 2° 2 BL passnd %
 28° L 69°L LZ" U “971 % *e3P43IN
 $8 8 Z°6 9°6 g Taebng-7T
 j 1 99°T vo 08" % “SuyyOoN
 | *OOIVAOL
 850°0 €90°0 2500 250° “ABTS 7 bw ~ er uOURy
 Cz cS 69 rg (xt AY) “Hd
 79 z9 °9. i) Cur Ay) Hd
 bit ral Vil €°8L “yo1s7ow el, 14
 Le 2°€ ze BE “qb ro / "Bw *433 er
 OL'L Sik

[Assistant]
LUTL Zul *9B15/*bw ‘aulzooLNy
 9°12 a'l2 plz €°€2 “3Bro/ Bw “ud
 06 9°83 0°6 96 ddd
 82 82 8z gz | “um *yzbua7 43Ng
 sFHOWS
 EL/6L/6 eL/ti6
 STLNSOY “ydas Ay “Bny “AY “OW-9 451
 3S8 OU0a THM ’ </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> -----Original Message-----
 From: Walk, Roger A.
 Sent: Wednesday, August 16, 2000 2:33 PM
 To: Solana, Rick P.
 Subject: FW: Potential recipients for PM's external research program information in Asia/Pacific
 Dear Rick,
 Below is Mingda's list. All but Dr. Prakit from Thailand are scientists of physicians and are active in research. All are
 very outspoken tobacco conirol advocates.
 Regards,
 Roger
 VCEVE6PLB80C </doc>


[User]
<|image|>Parse the text behind: <doc> JAN-18-02 FRE 10:09 AM
 RESEARCH FOUNDATION, INC.
 106 Johnson Building
 2035 E, Paul Dirac Dr., Box 15
 Tallahassee, FL 32310
 (850) 644-8650
 Payment Reference No.; RF 1 1300 0001 Invoice No.2
 AGENCY NAME AND ADDRESS: PROJECT TITLE AND NUMBER:
 Philip Mozris Human Sensitivity to ETS: Thresholds, Neural
 Research Center Mediation and Individual Differences
 P.O. Box 26583
 Richmond, Virginia 23261-6583 PROJECT PERIOD: PROJECT AMOUNT:
 07/01/00-06/30/02 $264,650.00
 PERIOD DESCRIPTION AMOUNT.
 WO/ATOL-L2/3 1/401 Payraent in accordance with terms of the ebove $48,016.43
 referenced project between the

[Assistant]
Florida State University
 Research Foundation and Philip Morris,
 under the direction of Dr. Jim Walker.
 Amount due equals twenty-two and one-half
 percent (22.5%) of estimated expenditures for all
 categories listed in the budget minus the equipment
 category.
 REMARKS:
 ® an Interim Billing
 This is invoiced to Date: $96,032.26
 © Final Buling Less Payments Received: $48,016.13
 Less Invoices Unpaid: 30,00
 This Invoice: $48,016.13
 Please address all questions to: Date:
 Getta Goodwin $50(644-3933} 12/31/01
 epoodwin@mailer.fsuedu
 PLEASE RETURN A COPY OF INVOICE WITH PAYMENT
 LZ£S8esss802 </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> Ua Sea sed
 Ra Retire et
 Cena oe
 SS Ren arte
 podria afectarie la salud.
 Dee Teen
 Ce arin se
 area See
 Ona tera sr ea Sanam
 ae acti’
 De cures
 PM3000152428 </doc>


[User]
<|image|>Parse the text behind: <doc> PAGE 1
 SOLD TO
 ELZZABETH GREER
 BUPLICATE
 63145
 DATE 44/48/77
 PURCHA
 ORDER NO.
 TERMS ¢,4,5,
 704
 FILLED ITEM ,
 QUAN. DESCRIPTION JNDEFENDENCE BY NUMBER | LOC. 4 3

[Assistant]
4 MARLBORO KING SOFT O56 7 4,76 he
 { MENTHOL MARLBORO KING 4046 43 476 6
 FILL AS SAND
 orn
 _. ®
 (he
 a” 6
 co Ny e
 LW ¢
 a to
 Be f2
 . [ 2 @
 t ad t t
 NScATION TOTAL PIECES Some
 KING, FILTERS & REG. - — @ ~
 SUPER 100’S
 2 CARTONS NET
 TOTAL @
 7.52 </doc>


[User]
<|image|>Parse the text behind: <doc> i ~ ™~
 CIGARETTE ADVERTISING CopE, INC. TE Ie
 S51 MADISON AVENUE
 5 NEW YORK, N.Y. 10010
 6863-2000
 March 1, 1967
 Cyril F. Hetsko, Esq.
 counsel
 American Tobacco

[Assistant]
Company
 150 E. 42nd Street
 New York, N.Y.
 Dear Mr. Hetsko:
 I am enclosing a copy of Donald F. Turner's
 reply to the Governor's letter of February 20th,
 together with a copy of that original letter.
 Sincerely,
 . ON 9 Q
 ‘. fr 4) elk
 * Ne ‘ y )
 Daniel B Goldberg
 Deputy Administrator
 DRBG:mi
 Encls.
 968011280 </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> "ee 5 ah Tk
 ‘ th ;
 -Are the. “condensations. providing y you wit
 oy ot - me 1 </doc>


[User]
<|image|>Parse the text behind: <doc> sooo Original Message-----
 From: Larson, Lynn E.
 Sent: Thursday, December 06, 2001 9:19 AM
 To: Alonso, Hector
 Ce: Gregory, Carla L.
 Subject: Document Request
 Good Morning Hector,
 Neither | nor our vendor could find the Proceedings of the Plant and Animal

[Assistant]
Genome Vil Conference, that you
 requested, in print. However, you may access all of the abstracts from that conference on the internet at:
 http:/Awww. inti-pag.org/7
 Please fet me know if there is anything else | can do.
 Take care,
 Lynn
 4-3642
 V6PPCPSS807 </doc>


[User]
<|image|>Parse the text behind: <doc> Ein, .
 Kaw Lepore
 C. I, McCARTY
 “ee R. A. Pittman °
 - ERNEST PEPPLES/dlt February 8, 1978
 Attached for your consideration and signature is the charter
 for a Brown & Williamson political contributions

[Assistant]
committee.
 The charter names Bob Sachs as Chairman and Jim Adams as
 Treasurer.
 As soon as your approval is secured the officers will proceed
 to organize and operate the committee.
 E. P.
 7 Attachment . </doc>


[User]
<|image|>Read the following text: <doc> - Me
 When several independent lines of scientific inquiry
 begin to mesh, there is usually an explosion of inter-
 est. Such an event is now occurring In the field of
 cancer research. Independent findings in medical ge-
 netics and tumor virology over the past 15 years have
 suddenly converged, focusing on the oncogenes. Med-
 ical geneticists who were studying the incidence of
 cancer in families evolved the concept that there were
 probably specific genes whose activities caused a spe-
 cific tumor. Genetic analysis of tumors brought to
 light the relationship between certain tumors and
 chromosomal abnormalities. At the same time, tumor
 virologists tdentified a number of viral genes that in-
 duce cancer in experimental animals. These currents
 of thought came together unexpectedly with the dis-
 covery that normal cells contain genes that are analo-
 gous to the known oncogenes in viruses. The possibil-
 ity that these bits of DNA represent etiologic steps
 from various stages In the genesis of cancer has gen-
 erated a burst of new activity in cancer research lab-
 oratories around the world.
 The work Iam going to discuss was designed to use
 viruses that cause cancer in animals as experimental
 tools to dissect the cancer cell. We began without any
 necessary hope that these animal viruses would cause
 cancer in humans. Instead, it was our bellef that a
 basic sequence of events must be involved in the evo-
 lution of a cancer cell, whether it ts induced experi-
 mentally by a virus or occurs spontaneously. if we
 could figure out how an experimental reagent like a
 virus causes cancer, then we could look for the same
 patterns in naturally occurring cancer and hope to
 find them.
 Why did we use a virus instead of a chemical, when
 we did not know whether viruses cause human can-
 cers and we were fairly sure that chemicals can? The
 answer is very simple: The interaction between a
 chemical carcinogen and a cell that triggers the devel-
 opment of cancer is not easy to study. It takes a long
 time for a chemical agent to induce cancer, and there-
 fore, the process is not readily accessible to analysis
 by biochemical and molecular dissection. In contrast,
 viral transformation of cells in tissue culture {s rapid
 and subject to biochemical analysis. Many tumor-
 igenic viruses have a single gene and, hence, a single
 chemical activity that ts responsible for transfcrming
 & cell into a cancer cell. Thus, tumorigenic viruses
 provide a shortcut to at least some of the chemical
 mechanisms that must be involved in carcinogenesis.
 There are always risks in simplificattons. Natural
 carcinogenesis is viewed as a multistep process. In
 using a virus that can induce cancerous growth Iiter-
 ally overnight. we may be circumventing all but the
 final step—the step that maintains the cell's cancer-
 ous growth. But since that fs the step we will want to
 understand if we are going to try to design rdtlonal
 prevention

[Assistant]
and therapy on the basis of what is wrong
 with a cancer cell, it is not a bad place to start.
 The Rous sarcoma virus was the first virus identt-
 fied that had oncogenic potential. It is a retrovirus,
 so-called because it replicates by means of RNA-di-
 rected DNA synthesis. Its RNA genes are copled into
 DNA by the enzyme reverse transcriptase, and then
 the DNA is inserted [or “Integrated") into the host
 cell's DNA Through integration, the viral genes be-
 Dr. Bisbop ts Professor of Microbiology, Untversity of Califor.
 nta, San Prancisco.
 Hosptial Practice August 1883 67 </doc>


[User]
<|image|>Read the following text: <doc> TO ALL NEW YORK OFFICE EMPLOYEES
 Introducing
 7O HILTER
 CIGARETTES
 PALL
 MALL
 LIGHT
 Auguat 1976
 We are pleased to announce
 the national introduction
 of PALL MALL LIGHT 100'S.
 New PALL MALL LIGHT 100's
 hag the most flavor you
 ean get in a low tar
 cigarette!
 PALL MALL LIGHT 100'S
 is now available at the
 Employees Retail Store
 on the second floor and
 from the vending machines
 on the second and fifth
 floors.
 Txy PALL

[Assistant]
MALL LIGHT 100'S -
 only 12 mg, tar!
 eg Gavbeeo~
 Pp, F. Paoluccio
 Executive Sales Manager </doc>


[User] <|image|>what is written in the image?

[Assistant]
<doc> PHILIP MORRIS USA INTER-OFFICE CORRES PONDENC
 120 PARK AVENUE, NEW YORK, NY 10017-55
 TO: Arun Sinha DATE: December 4, 1992
 FROM: Karen Miller/S. Kieffer
 SUBJECT: CAMBRIDGE FOCUS GROUPS (Denver, 11/30 - 12/22
 BACKGROUND
 Who:
 Regular users of Cambridge and Doral
 Occasional users of Cambridge and Doral
 Previous Cambridge smokers
 Objective:
 To explore cigarette brand preferences and purchase behavior
 and the factors influencing change in these, and brand imagery.
 OVERVIEW:
 There were many similarities noticed between Cambridge and
 Doral smokers in terms of their purchase patterns, motivations and
 attitudes toward their own brand.
 Overall, these smokers are very price savvy. They know what the
 different brands cost, what coupons are available, what stores charge
 less, etc., and they take advantage of price deals whenever possible.
 Coupons/retail call outs/in store presence/POS are requirements
 for success in this category/among this smoker group. They need to
 feel that they are getting a savings on a ‘quality’ productona
 regular basis (potentially in opposition to an everyday low-
 price/generic positioning). ,
 FINDINGS:
 Brand Preferences
 Cambridge smokers seemed to be somewhat less loyal than Doral
 smokers in terms of consistency in brand purchase--tied mainly to
 8SZ0E6002 </doc>


[User] <|image|>Decode text from the snapshot.

[Assistant]
<doc> Po / R' 2-35-72
 yg -45
 pe 073-92364
 ae ph a a A Tee
 etn oe oy eer OF ane Gos
 Dominican Republic Test #40, MR4-03AB
 DISTRIBUTION
 Mr. H. Cullman Me. F. A. Lowman
 Mr. A. C. Britton Mr. E. A. Leon
 Mr. G. W. Macon, Jr. Mr. J. B. Block
 Mr. C. E. Salguero Mr. L. Hannemann
 Mr. W. G. Lloyd Mr. R. A. Hutchinson
 Mr. J. ¥. Mason, Jr.
 WRITTEN BY: + hoa Lf . bofane
 APPROVED BY: Nn / ¢ Chaho
 _ DATE: January 30, 1973
 66EP920002 </doc>


[User] <|image|>what does the image read?

[Assistant]
<doc> Og dee
 SURGEON GENERAL'S WARNING: Smoking
 Causes Lung Cancer, Heart Disease, —
 Emphysema, And May Complicate Pregnancy. </doc>


[User]
<|image|>Continue reading the text: <doc> -34-
 Biographical Sketch of: Mark H. Ginsberg, M.D.
 Born: August 30, 1945
 Education:
 McGill University, Montreal Canada, 1962-65, B.S.
 State University of New York, Downstate Medical Center, 1970, M.D.,
 summa cum laude.
 Professional Record:
 Medical tnternship, University of Chicago Hospitals, Chicago, illinois, 1970-1971.
 Medical Resident, University of Chicago Hospitals, Chicago, illinois, 1971-1973.
 U.S.P.H.S. Trainee in Rheumatology, Department of Medicine, University of
 Chicago, Chicago, {llinois, 1973-1975.
 Postdoctoral Fellow, Departments of Allergy and Immunulogy and Immunopathology,
 Scripps Clinic and Research Foundation, La Jolla, California, 1975-1977.
 . =)
 Research Associate, Department of Immunopathology, Scripps Clinic and
 Research Foundation, La Jolla, California, 1977-1978.
 Assistant |, Department of Immunopathology, Scripps Clinic and Research
 Foundation, La Jolla, California, 1978-present.
 Honors and Awards:
 McGill University Scholar, 1963-1965. _
 Boris Muskatov Prize in Psychology, McGill University, 1965.
 Downstate Honor Scholarship, i970.
 First Prize, Downstate Honors Day Symposium: Steroid Metabolism in a
 , Primative Erythropoietic System, 1970.
 Clinical

[Assistant]
Investigator Award NIAMDD
 Professional Organizations:
 Alpha Omega Alpha, New York
 First Vice-President, Eta Chapter, Alpha Omega Alpha
 American Rheumatism Association
 American Association of Immunologists
 American Federation for Clinical Research </doc>


[User] <|image|>Parse text from imagery.

[Assistant]
<doc> ore
 LIBERTE LS
 MUTUAL
 {ITT Mua BAUER COREY = LAE ATUL AE MEUARE DOUPARY + sae
 Make check payable to Liberty Mutuai and mail with a copy of this invoice to:
 P.O. BOX 876, LYNBROOK, LONG ISLAND, N.Y. 11562
 m PHILIP MORRIS INCORPORATED ETAL |
 100 Park Ave
 New York, NY 10017
 ATT: Mr. Paul Goldechmide pate AUG 1 1977
 L wd
 PREMIUM INVOICE
 Policy Number Anount Due
 WC2-621-~004066-197 D94/5
 WO1-621~-004066-187 1D94/8
 WC2~621-D04066-04 YTD594/9
 LG1-621-004066-025 94/0
 AB1-621-004066-035 TD94/4
 AMI-621-064066-057 1D94/8
 “§366600.00-
 This invoice is payable on the above date in accordance with
 the terms of the listed policies
 NEW-1 | . FOR LIBERTY MUTUAL USE Aud.
 ES, Date 1/ 1/77 ___ Salesman heb Composite] Yes (] No’ Acct.
 REN-2 {X Stat
 State MultL Office. 202 Adj. Basis 8] 4(4 20) Work Units WC3-1_ GL3-_1_.
 PA 232 AD Printed in USA.
 STISEEZEI0? </doc>


[User] <|image|>Detect words in the photograph.

[Assistant]
<doc> JULY 9, 1963
 MR. JOS. F. CULLMAN, 3rd
 PRESIDENT, PHILIP MORRIS INC.
 ANSWER TO QUERIES ON JULY 9th
 STATEMENT OF TOBACCO: INSTITUTE
 PRESIDENT GEORGE V. ALLEN:
 “PHILIP MORRIS' ADVERTISING POLICY HAS FOR SOME TIME
 CONFORMED TO THE PRINCIPLES SUGGESTED BY THE TOBACCO
 INSTITUTE." </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> Associated Press
 BROOKLYN, Mich.—Nigel
 Mansell was almost awestruck by
 his victory Sunday in the Marl-
 boro 500.
 sell, who battled a raging head-
 ache, the rough Michigan Interna-
 tional Speedway oval and the ear-
 ly loss of his on-board telemetry
 to win in only his second 500-mile
 race. “I’ve never been in
 a race like this. This is
 one of the greatest victo-
 ries in my career.. It
 makes me very proud to
 win on a circuit like
 this.”
 Mansell, who made his
 racing mark on the For-
 mula One circuit, out-
 dueled Newman-Haas
 Racing teammate Mario
 Andretti to win for the
 third time in his sensational rook-
 ie season on the IndyCar tour. He
 also regained the series points
 lead over Emerson Fittipaldi, who
 struggled toa 13th-place fish on
 the hot, humid afternoon.
 Mansell took the lead ‘:om
 pole-winner Andretti on the 28th
 Jap and led all but’two of the last
 221 laps, including the final 167.
 Mansell, who finished third to
 Fittipaldi in his first Indianapolis
 500 in May, had more problems
 with the rough track and the heat
 than he did with any other driver
 in the 28-car field.
 “I’ve never driven anything like
 it in my life, and it’s beaten me,”
 he said. “I’m glad there weren’t
 another 10 laps.
 end, and I don’t mind telling the
 world I’m tired.
 “TI don’t know how you train or
 practice for a 500. I think you've
 got to do a few before you know
 how to do it.”
 Asked about Mansell’s showing
 this season, Andretti said, “It’s
 definitely very impressive. I’m not
 surprised, though. I knew he had
 the ability, and he’s been fast
 everywhere.
 “He’s a fast learner,
 that’s for sure.”
 Mansell lost his telem-
 etry after the fifth lap
 and had no dashboard
 readout of speed or fuel
 load. :
 He had to use his ta-
 chometer to gauge his
 4 speed and depend on
 team manager Jim
 sions for information.
 “Jim McGee shouted at me ev-
 ery lap for the last 25 laps,” Man-
 sell said.
 “T didn’t know how fast I was
 going out there, and he was giving
 me the [time] splits between me
 and Mario.”
 Mansell crossed the finish line
 9.434 seconds ahead of Andretti,
 with Arie Luyendyk a lap down in
 third and Boesel another lap back
 in fourth. Scott Goodyear was
 three laps back in fifth.
 Mansell averaged 188.203
 m.p.h., which fell just short of
 racing's 500-mile record of 189.727
 set by Al Unser dy. in this race in
 1890.
 eveo6lesoc </doc>


[User]
<|image|>Read the following text: <doc> PLEASE TELL US WHAT YOU THINK
 1. How did you contact Consumer Relations.
 ia By Telephone [_] by tetter (If by letter, please skip to question 4.)
 How satisfied were you in each of the following areas:
 Neither
 Very Somewhat Satisfied Nor Somewhat Very
 Satisfied Satisfled Dissatisfied Olssatisfied Dissatisfied
 2. EASE OF CONTACT:
 * — Ability to get through on first call
 * Length of time on hold
 3. PERSONNEL:
 e = Courtesy
 * = Professionalism
 ® §Knowledge
 UOOO UU
 MHEM OO
 OOOO
 OOOO
 OOOO Of
 « = Authority to resolve problem/
 answer question
 4. RESPONSE
 * Timeliness
 © Clarity
 * ~~ Helpfulness
 HOOU
 HOW
 OKO
 OOOO
 KOOO
 @ ~~ Follow through on promised action
 5. How many times did you have to contact the R. J. Reynolds Consumer Relations Department before your question/problem was
 answered?
 1 2 3 4 4+ Final Action Still Not Taken
 6. If you were referred to a different 800 number after reaching an R. J. Reynolds Company representative, were you satisfied with the
 response?
 Not Very Somewhat Neither Satisfied Somewhat Very
 Referred Satisfied Satisfied Nor Dissatisfied Dissatisfied Dissatisfied
 Oo Oo o o o
 7. Which ONE of the following statements BEST describes the way you feel about the action taken by the R. J. Reynolds Consumer
 Relations Department to respond to your request for assistance?
 [_] was completely satisfied.
 CL) 1 was NOT completely satisfied but the action taken was acceptable.
 | {was NOT completely satisfied but some action was taken.
 [-] _ ! was NOT AT ALL satisfied with the action taken.
 4 Iwas NOT AT ALL satisfied; no action was taken.
 8. Based on how well you were treated by

[Assistant]
our representative, will you continue to purchase the brand of cigarettes you contacted about?
 | Definitely | Probably } Might or | Probably | Definitely
 Would Would Might Not Would Not Would Not
 O O A Ol vd Aw
 Wis Feng You WAve A6Y Seat pay aS Me °
 6 PAce eT LDUUsAn J BLACK Bee 13-67
 EPPS LBvTsS </doc>


[User] <|image|>what is written in the image?

[Assistant]
<doc> “Cc alle rere ve:
 J. T. Baker Chemical Co. ee
 222 Red School Lane aoooa269g8 —
 “EBaices reece — MUNIN
 Chemtrec # (800) 424-9300
 ® .
 8 National Response Center # (800) 424-8802
 (S05 4#O2699
 Coury -02 Cadmium Acetate, Dinydrate Page: 1
 Effective: 09/10/86 Issued: 12/02/86
 wee wen uenw ane ene ee eee EE EE ES SS eee
 SECTION I - PRODUCT IDENTIFICATION
 et EE BE EES REE ERR REE RSS SSE SESS SS SSS RR SS SSS SS SS
 Product Name: Cadmium Acetate, Dihydrate
 Formula: (CH. COO) _Cd+2H 0
 3 2 2
 Formula Wt: 266.52
 CAS Wa, | 05743-04-4
 NIOSH/RTECS No.: AF?5S05000
 Cammon Synonyms: Acetic Acid, Cadmium Salt, Bihydrate
 Product Codes: 1190
 _ PRECAUTIONARY LABELLING
 BAKER SAF-T-DATA Sustem
 HEALTH FLANMABILITY REACTIVITY CONTACT R E C E | V E D
 2, 3 | 0 | 0 | | 3 |
 _ SEVERE | NCNE NOHE SEVERE J A N ” 2 {08/
 Laboratory Protective Equipment
 . r J. J. CACCIOTTI
 ceeses a a GLOVES
 Precautionary Label Statements
 POISON! DANGER!
 HAY BE FATAL IF SWALLOWED OR INHALED
 EXCEPTIONAL CONTACT HAZARD - READ MATERIAL SAFETY DATA SHEET
 MOTE: REPORTED AS CAUSING CANCER IN LABORATORY ANIMALS , EXERCISE DUE CARE.
 Do not get in eyes, on skin, on clothing.
 Bo not breathe dust. Keep in tightly closed cantainer. Use with adequate
 ventilation. Wash thoroughly after handling.
 OSTEERLSOZSY
 —" SECTION Ii - HAZARDOUS COMPONENTS - ; _ —_
 ee een SN
 Cadmium Acetate, Dihydrate 90-100 5743-04-4
 a For information only; anhydrous form ~ §a3-30-8
 Continued on Page: 2
 meanaed on Page’ 2 4g </doc>


[User] <|image|>list the texts in the picture.

[Assistant]
<doc> DATE: Bo 77
 3 Tachi RC, 6-447
 , pot feted
 DATE SANPLE I.D, DILUTION |ABSORP'TION CONCN » ACTUAL CONCH:
 £4) HY foe (N50 WAT A TA | OG f,36
 . 3h (150 4 ARS | 0.625
 TP hatin 00% peckegle
 BAAN hiw® | fo | Se Wo?
 82-91 7 Abin © xe 084 / we hile motel
 BAT Reb 450 Olo Lie . _
 sy Fy htm. | v3 __|
 Sty is S| yo | oe )
 8-2-9 |Fenef Chua aa (ol O97. BIS Laas 2.3
 hat | LY] 210 |_ 16.5 ~
 ss 3-4 \Jues § 10K 097 LAYS lye fo
 ys oy RC
 the le | Bd | ee [Sith \
 44-4 met 4 | of 090 Aas | 1B
 “fs | [al 362. | (8./
 y-<4¢ Bol % Tse “ Yo 234 a 3, 33
 (en Oe MZ 14! £310 MS
 6-6-4) Hoek | eho Jae | asp | ps
 Mos ko go 8) EI ng
 61-4) Pomb "7" | ofp | gn 24S |Ldy
 OP 4 * |e |e 25 | AAP IER 63
 SS GR) —— >
 Lathlaog XY Congo woe) AF SLY Phi EL
 6-4 | See, Had TE ASSO As] WEG LYD
 BTU See. Meat Th | aso 3) | GIA [134 </doc>


[User] <|image|>Deciphering written content in the photo.

[Assistant]
<doc> Alessandro Guidotti Professor
 University of Florence, Italy Baccal 1957
 University of Florence, Italy M.D. 1961 Medicine
 PROFESSIONAL EXPERIENCE:
 1961-1964 Postdoctoral Fellow, Department of Pharmacology, University of Florence, Italy
 1964-1965 Postdoctoral Fellow, National Italian Research Council
 1965-1968 Assistant Professor of Pharmacology, Department of Pharmacology, University of Florence. ftaly,
 Visiting Scientist Department of Pharmacology, Oxford, England (1966, 6 months).
 1968-1970 Professor of Pharmacology, Department of Pharmacology, University of Florence, Italy
 1970-1972 Visiting Associate, Laboratory of Preclinical Pharmacology, National Instiute of Mental Health,
 Saint Elizabeths Hospital, Washington, D.C.
 1973-1975 Acting Chief, Section on Neuroendocrinology, Laboratory of Preclinical Pharmacology, NIMH,
 Saint Elizabeths Hospital, Washington, D.C.
 1975-1985 Chief of the above section
 1985-1994 Deputy Director, Fidia-Georgetown Institute for the Neurosciences, Georgetown University,
 Washington, D.C. and Professor of Pharmacology
 1992-1994 Acting Director, Neuroscience Training Program, Georgetown University
 1994-1996 Acting Director, Center for Neuropharmacology, Nathan S. Kline Institute for
 Psychiatric Research, Orangeburg, N.Y.
 1995-1996 Research Professor, Environmental Medicine, NYU Medical Center.
 1996-Present Professor, Psychiatric Institute, Department of Biochemistry and Psychiatry, College of Medicine,
 University of Illinois at Chicago, IL
 SOCIETIES:
 1962: Italian Medical Association, 1962: Italian Society for Pharmacology, 1973: American Society for Pharma-
 cology & Experimental Therapy, 1973: Society for Neuroscience, 1974: International Society for Psychoneuro-
 endocrinology, 1980: International Society of Neurochemistry, 1989: American College of Neuropsychopharma-
 cology, 1989: Collegium Internationale Psychopharmacologium, 1993: American Society of Neurochemistry
 EDITORIAL POSTS:
 Journal of Neuroscience Methods, Life Science, Neuropharmacology, Pharmacological Research Communications,
 Regulatory Peptides, Drug Development Research, Epilepsy Research, European Journal of Molecular Pharmacology
 40050509 </doc>


[User]
<|image|>Read the following text: <doc> E 3 TAT RICAN Memorandum
 ee iA TOBACCO
 Resear
 To Mr. R. S. Sprinkle, III Dae = - 7/26/90
 fon BL F. Price
 Ret Weekly Report - Research and Technical Services
 "Smokeless" cigarette efforts involved additional analysis of controlled-
 release fuels that did not heat release.
 Burn regulation work is summarized below:
 PALL MALL Famous model cigarettes in test series BR-8 consist of control
 and TC-129A blends wrapped with 878 and 106 "P" papers. The 878 models on
 batting, crevice/covered, produced 0 of 5 extinguishments and 4 of 5
 ignitions for the control and 0 of 5 and | of 5, respectively, for TC-129A.
 Both models produced the same results on flat/uncovered, 0 of 5 and 4 of
 5, respectively. For 106 "P" contral, on flat/uncovered, there were 0 of
 5 extinguishments and 5 of 5 ignitions; the TC-129A cigarettes produced 0
 of 5 and 4 of 5, respectively. These results may change, with new batting
 expected the first of next week; present batting does not fluff to speci-
 fied thickness.
 Problems with foam continue, with 0 of 5 ignitions in crevice/covered
 configuration. We should receive four sheets with higher air permeability
 early next week.
 Linear burn rate studies in the CORESTA enclosure with fan-induced flows
 are confusing. We will discontinue this route and wait for additional
 fabric and cigarettes before continuing. Some work by R. J. Reynolds
 shows cigarette A, from the first collaborative, to cause ignitions at a
 higher potassium level than regular blend. Cigarette A is all expanded
 blend, 5 CORESTA and no citrate. Cigarette J in the last collaborative
 used 10 CORESTA and citrate. Cigarettes BELN and BELC from the TSG work
 have ignitions consistent with projections.
 We examined potassium-treated fabric used in the CORESTA work by TGA-FTIR.
 Increasing potassium levels causes small decreases in

[Assistant]
decomposition tempera-
 tures, a decrease in volatile organics, and an increase in carbon dioxide
 indicating an increased oxidation efficiency. Carbon monoxide is un-
 affected.
 The Fire Safety Cigarette Bill cleared subcommittee with a Boucher amerid-
 ment extending the study from 30 to 36 months. It is expected to quickly
 clear the full committee and go to the House for vote. </doc>


[User]
<|image|>Read the following text: <doc> MEMORANDUM
 January 4, 1994
 To: Mr. R. Hammer
 From: R.S. Goldbrenner, Esq.
 Re: Harley-Davidson in Asia
 Mr. Chris West of Red Line Trading Company contacted me today
 in regard to representations made to them by Aragon, Inc. Mr. West
 expressed

[Assistant]
an interest in buying Harley-Davidson cigarettes. for
 distribution in Japan, China, Singapore, South Korea, Vietnam and
 Thailand. His telephone number is (714) 665-6990 and the number
 which he may be paged, if unavailable at the former number is
 (714). 237-4628.
 rhi494
 SE9TLLIS </doc>


[User] <|image|>Recognize text in the image.

[Assistant]
<doc> mee ‘ey
 . . . ° on wets . _«*
 . , o
 ‘ :
 S.T.S. BELGIUM, Switch Techndjogy service sprl .. “* ONE DAY -STAMPS.s
 , : mo oo ARR R RRR RR
 ,OTYA) 428.423.2168 . Chausaée de lofvain, 160. TEL. 02/ 230.17.73
 ROB 477.631 1030 Bruxpllee os _ FAX. 230.8312
 “LR 6210-0459960- 23 ee 7
 -- Adresse ‘de livraison ---- ~~--“adresse de facturation ----
 - - *ssprl GRC - CONTRACT RESEARCH CENTER -
 a nos . . ~- fe .
 Sg AW DU PEAGE Lorc) PE
 “4 1932 ZAVENTEM OE asd
 . | {et
 Document Numéro Date | Code - Client - ; . TV»
 4 vote de crédit 7054 (18/12/91) 3835 - 435085085
 © Rod . a . |
 TERRE 0 DESIGNATION, = QUANT pUsHTVA) © roraL ty)
 BON "N° L4095/LIVR:CRC+- ‘CONTRACT/MONTANT: -51205/RESTE “A PAYER +5105,
 ‘fe. “OTE DE CREDIT SUR FACTURE §999 . -1 4289.92 = 1290 19
 TGLLZLSZ0Z
 TVA 0 6M 1TH OR . Totaux, +
 BASE 0 ~* 0. | Ma290:
 MONTANT * O- 00S BIB
 “x _
 _ Modes ¥e. Paiements: mo
 Liquide... 0 _ Carte fidelite .
 Cheque "= =: = 0. Carte crédit::
 Mister Cash .. 0. A terme fact. .
 Ax ats
 -5105 | | </doc>


[User] <|image|>Detect words in the photograph.

[Assistant]
<doc> Weekly Highlights Date: August 14, 1981
 Ron Sustana From: David Fishel
 I, A news conference has been scheduled by Sen. Tom Smith,
 II.
 chairman of the South Carolina Tobacco Advisory Commission,
 for 1l a.m. Wednesday, Aug. 19, to honor R.J. Reynolds
 tobacco. The conference will be to show the display --
 which contains oversized photographs and copy blocks -- to
 media and legislators. It will be held at the State
 House and will include a number of speeches of appreciation
 by South Carolina dignitaries. The display is. entitled :
 "Pride in Tobacco/South Carolina Tobacco Advisory Commission/
 Together We Mean Business." os
 Jane Carroll, marketing columnist for the San Francisco
 Examiner and Chronicle Sunday edition has agreed to write
 a story on the resurgence of the Camel brand.
 thhg LtzoS © </doc>


[User] <|image|>Retrieve written information from the image.

[Assistant]
<doc> "FOR ACCOUNTING USE ONLY
 One MORRIS | VOUCHER wumaer G39 336
 1.i COMPANIES
 ( CAPITAL CORP.
 {i MANAGEMENT CORPORATION
 U1 INCORPORATED oo V O U Cc H E R
 CIMIT IF NO SPECIFIC DATE REQUIRED)
 [DATE VOUCHER IS PREPARED (oi oF
 | | Kush DATE DUE: ¢/1/91 TIME
 [PAYEE ACCOUNTING CODE s
 ‘ a " 89,213.00
 Covington & Burling
 = os - 9-301 -6€12
 1201 Pennsylvania Avenue, NW ‘
 Washington, DC 20044 Mailroom 1B rota, | * 89,213.00 y
 APPROVALS (Pane PAY Ny EXPLANATION Ehred MENT Chmere space required, see back page) /
 Mm. zing f . whe ,
 | COMPLETE THIS SECTION IF RETURNED CHECK 1S REQUIRED — 7 a
 RETURN TO: NAME DEPARTMENT st |-BUILDING/FLOOR | PHONE EXT.
 REASON FOR REQUEST: - a The
 f _ ACCOUNTING USE ONLY
 VENDOR # I I 3042 COMPANY OOF. (005-COMPANIES; 009-MANAGEMENT, 010-INCORPORATED)
 - VOUCHER TYPE © (i-Reg: 2-P.Pj 3-C.M.; 4-D.M.; 5-C.P;6-V.C.;7-V.A.) VOUCHER/INVOICE DATE_9°22.9/ __
 SEPHND--> _ RTIIt (-SM RTNAME <--> —_—
 (CHECK Dare) (CHECK NBR)
 CONTRACT -> ____._ . FREQUENCY _
 (#121300) |
 Lr LINEoD! conp/accr 21 of 1 009 O60 6/200, 30/0000.
 , a. AMT/PCT -> __87 ) A ID/IBRCD--> £. ee
 DESC -> 7 Gan aly [Meech mating
 Wace
 LINEOO2 CORP/ACCT.OL — we ee ge STs
 — AMT/PCT-> A ID/BRCD--> 2 a >
 DESC -> . \
 “LINEOO3 CORP/ACCT.% OO 2
 — AMT/PCT-> A ID/BRCD-->_ oo
 DESC -> i o
 — Fi] LiNEO0g = =CORP/ACCT 01 i 3
 reel. AMT/PCT =: :
 DESC -> RECEIVE
 a 453 1991
 LINE9005 CORP/ACCT 04 yi 38
 i — AMT/PCT-> _ . aD wr ~ 4 _ <
 peepee et =~ R BONENS
 i We oe
 wi : WEE. pemrtsonents See 2
 Fis
 ‘Latéiiven own ey tay ABSMOVAL
 FORM e488 XY Pi INGIISAICO 5 REV 190 COMP Ago rh
 : gana :
 we ere a </doc>


[User] <|image|>what is written in the image?

[Assistant]
<doc> TO:
 FROM:
 SUBJECT:
 INTER-OFFICE CORRESPONDENCE
 120 PARK AVENUE NEW YORK, NY 10017-5592
 DATE: September 11, 1991
 Don Frid
 1992 Annwal Meeting - Shareholder Proposals
 Reference is made to my memorandum dated September 10 with
 respect to my discussions with Reverend Michael Crosby of the
 Corporate Responsibility Program,
 I have just been advised by Father Crosby that the second
 shareholder resolution attached to my memorandum is not the
 one he plans to submit to Philip Morris. Rather, what he
 intends to submit is the attached resolution which is
 identical to that submitted last year and which, because of
 the vote obtained last year, will have to be included in this
 year’s proxy statement,
 Since the proposal relates to warning labels, I would
 appreciate the Philip Morris International Corporate Affairs
 Department advising me, based on 1990 sales, the percentage
 thereof that, if made in 1992, would not bear warning labels.
 DF ssf
 attachment
 1992 Ani Mtg-Shldr Prop-Rev,Crosby-Memt2
 Distribution:
 .Bible
 Bring
 -Buzzi
 .Campbell
 .-Carney
 - Knox
 -Malzacher
 -Miles
 -Moreno
 -Murray
 .Nelson
 .Parrish
 -Pollak
 -Whitson
 GUMOENME VHP APrEA
 cerecersde
 FELTETSEOS </doc>


[User]
<|image|>Read the following text: <doc> Date WED, NOV 23,
 Test Number: PD03002
 Priority:
 Requested By:
 Related Test Number:
 Classification:
 Test Purpose:
 Making and Packing Date:
 Type of Panel Testing:
 Keyword(s): NONE
 Brand Name:
 Special Instructions:
 TOBACCO PROCESSING:
 FILTER MAKING:
 MAKING & PACKING:
 SAMPLING TYPE:.
 _ Carbowax fact. 8
 pot
 FINAL SPECIFICATION
 1988, 1:11 AM Page 1 of
 Program Number: i112
 ARZONICO, B. W. (0843) Date Requested: 881018
 Division: 581

[Assistant]
TF NM
 AIR DILUTION AS A VARIABLE FOR TAR DET.
 Mail Out Date:
 MAKE BLEND AT R&D
 MAKE FILTERS ON KDF-@ USING PELLET INSERTION
 MACHINE. CALL B. ARZONICO OR BARRY SAINTSING
 FOR STRAND MATERIAL. ALL PARTS USE 6% SPEARMINT.
 MAKE IN PILOT PLANT ON MARK 9. CALL BARBARA
 ARZONICO PRIOR TO MAKING. TEST INVOLVES LASER
 SETTING CHANGES ONLY. (MACHINE #3)
 PART "G" USES SPECIAL TIPPING PAPER (M2252)
 (VANILLIN-FLAVORED) TO BE SUPPLIED BY B. ARZONICO
 SEO: 6690S </doc>


[User] <|image|>Retrieve written information from the image.

[Assistant]
<doc> NIELSEN, HODGSON, PARRINELLO & MUELLER
 VIGO G. NIELSEN, JR.
 ATTORNEY AT LAW
 BACRAMENTO OFRICE
 (030 FIFTEENTH STREET, SUITE 250
 SACRAMENTO, CALIFORNIA 95614
 TELEFHONE (G16) 448-6752
 THE HARTFORD BUILDING
 SSO CALIFORNIA STREET, SUITE 2850
 BAN FRANCISCO, CALFORNIA 4108
 TELEPHONE (4151 989-6800
 TCAL0249222 </doc>


[User]
<|image|>Parse the text behind: <doc> oe,
 RJ, Reynolds Tobacco Gompany
 Discussion Guide
 CONTACT: Bz Arey SY¥one TITLE: SV Coordinater/ C orp. Numarn—
 COMPANY: Yariv tie PHONE: __ 703 -97¢- 7 oe v esouren¢
 CITY: Denver STATE: CO DATE: FLi8/ 4 |
 Ud IEF SY.
 Denver, Co ME SOLO LZ. ‘
 Hello, my name is . I am calling from the Public Policy
 Research Group which is a national research organization that
 conducts studies on issues of national and local importance. We are
 currently researching how the nation's largest companies are
 approaching the issue of smoking in the workplace. Would you be
 available to participate in the short study?
 1. Are you the person within who is responsible
 for geveloping or reviewing your company's approach to smoking
 in phe workplace?
 YES NO
 [IF NO: Ask which department or person is responsible for
 developing or reviewing the

[Assistant]
company's approach to smoking:
 2. Does four company have a formal policy regarding smoking by
 empYoyees in the workplace?
 —/ YES NO
 [IF NO, go to Question # 12.)
 3. Is your company’s smoking policy distributed to employees in :
 writing? . wr.
 YES NO sot cet Ms NG
 vo #
 4, What is your company’s policy toward smoking?
 { [CHECK APPROPRIATE ANSWERS. } vik
 ee oo
 fl +++ Smoking is allowed throughout the company
 f +++ Smoking is allowed in designated areas
 yh ee- Smoking is not allowed in company buildings at. all
 e-+ Smoking by employees is not allowed at any time ;
 e+- Employees can be fired for smoking either on or off the job
 +--+ Paople who smoke are not hired
 e»+ Smokers pay more for health insurance
 s-- Other:
 (please turn)
 @9ST SLLOS </doc>


[User] <|image|>what does the image read?

[Assistant]
<doc> IMAGE
 NOT
 AVAILABLE
 ONLINE
 The material referenced in the associated
 index listing is available in the Minnesota
 Tobacco Document Depository. Please
 see this website's home page for additional
 information regarding the Depository. </doc>


[User]
<|image|>Parse the text behind: <doc> October 27, 1999
 Via Fax and U.S. Mail
 Mr. Geoffrey Bible
 Chairman & CEO
 Philip Morris Companies
 120 Park Avenue
 New York, New York 10017
 Dear Mr. Bible:
 After decades of denial, your company has now acknowledged the overwhelming
 scientific and medical consensus that cigarette smoking causes lung cancer, heart
 disease and other serious illnesses, and is addictive. Your public admission brings with it
 the responsibility

[Assistant]
for action — not just words — to begin to reduce the more than 400,000
 annual deaths fram tobacco in the U.S.
 Philip Morris also must take responsibility for the fact that more American children, both
 boys and girls, smoke your Marlboro brand than ail other cigarette brands combined,
 and that Marlboro is the number one cigarette among children woridwide. This is not a
 coincidence. Your marketing strongly influences children to begin to smoke and in brand
 selection. Of the more than 3,000 American children who become regular smokers every
 day, at least 1,800 of them are smoking Marlboro.
 Unless you undertake the following important actions to reduce the toll of tobacco, your
 statements can only be seen as a public relations gesture rather than meaningful
 corporate change. ‘ ‘
 « End your opposition to the reasonable regulation of tobacco products by the Food
 and Drug Administration, and drop your lawsuit against FDA. Since you now admit
 that your products are addictive and experts agree they cause serious disease, they
 should not escape the same level of government oversight as drugs, medical devices
 and other products regulated by the FDA. It is also time to end the smokescreen that
 FDA regulation of tobacco will inevitably lead to a ban on cigarette sales to adults.
 The FDA has never advocated or supported a ban on cigarettes, nor have we.
 e Stop all marketing practices that impact children. Eliminate the use of human
 characters in your advertising, including the Mariboro Cowboy, and western imagery.
 Curb your pervasive in-store advertising in convenience stores and other retail
 outlets frequented by children and in publications with high youth readership. And
 end sponsorships of public events that can be attended by children or are broadcast
 on television.
 e Take action to reduce the ease with which kids illegally obtain cigarettes by
 permitting your products to be sold only in stores that place cigarettes behind the
 counter, and eliminate vending machine, Internet and direct mail sales.
 e Revise your “youth anti-smoking” advertising by telling kids the truth: that smoking
 kills and is addictive. Otherwise, end the charade that you are trying to discourage
 youth smoking.
 6262720202 </doc>


[User] <|image|>Parse text from imagery.

[Assistant]
<doc> From:Martin, Diana J.
 To:Dibencdetto, Charles <DM> 1224; Young, Mark <RSM> 1200
 ce:
 BCC:
 Primary Date: 10/21/1997 8:45:19 AM
 Last Modified Date: 1997-Dec-11 07:31:46
 Last Touched Date:
 Sent Date: 1997-Oct-21 08:45:19
 Received Date: 1997-Oct-21 08:45:19
 Subject:
 Attachments:
 MWS6.D0C
 2482 8Elz¢
 RJR24070048
 70004 1442
 ee CT </doc>


[User] <|image|>Identify text in the picture

[Assistant]
<doc> BIOGRAPHICAL INFORMATION
 NAME: TITLE:
 Douglas Dillon Taylor Associate Professor
 DATE OF BIRTH CITIZENSHIP SEX
 8/29/55 U.S.A, Male
 EDUCATION
 INSTITUTION & LOCATION DEGREE YEAR SCIENTIFIC FIELD
 University of Richmond BS, 1976 Chemistry &
 Richmond, VA Biology
 Bowman Gray School of Medicine M.S. 1978 Biochemistry
 Wake Forest University Ph.D. 1982 Biochemistry
 Winston-Salem, N.C.
 Boston University School of Medicine Postdoc 1985 Tumor
 Boston, MA Immunology
 RESEARCH AND PROFESSIONAL EXPERIENCE
 1995 - present Associate Professor, Department of Obstetrics and Gynecology, University
 of Louisville School of Medicine, Louisville, KY
 1992 - present Assistant Professor, Department of Biochemistry, University of Louisville
 School of Medicine, Louisville, KY
 1992-1994 Assistant Professor, Department of Obstetrics and Gynecology, University
 of Louisville School of Medicine, Louisville, KY
 1988-1992 Associate Member, Division of Medical Sciences, Fox Chase Cancer Center,
 Philadelphia, PA
 1988-1992 Director of Research, Department of Surgical Oncology, Fox Chase Cancer
 Center, Philadelphia, PA
 1988-1992 Assistant Professor, Department of Surgery, Temple University School of
 Medicine, Philadelphia, PA
 1989-1992 Adjunct Assistant Professor, Department of Biochemistry, Temple
 University School of Medicine, Philadelphia, PA
 1987-1988 Assistant Professor, Department of Microbiology, Boston University School
 of Medicine, Boston, MA
 1985-1987 Instructor, Department of Microbiology, Boston University School of
 Medicine, Boston, MA
 REPRESENTATIVE PUBLICATION (of 30 peer reviewed total):
 D.D. Taylor and G.d. Doellgast. Quantitation of peroxidase-antibody binding to membrane
 fragments using column chromatography. Analytical Biochemistry, 98:53-59, 1979.
 D.D. Taylor, H.D. Homesley, and G.d. Doellgast. Binding of specific peroxidase-labeled
 antibody to placental-type alkaline phosphatase on tumor-derived membrane
 fragments. Cancer Research, 40:4064-4069, 1980.
 D.D, Taylor, H.D. Homesley, and G.J. Doellgast. Membrane-associated immunoglobulins in
 cyst and ascites fluids of ovarian cancer patients. American Journal of Reproductive
 Immunology, 3:7-11, 1983.
 D.D. Taylor, H.D. Homesley, and G.J. Doellgast. Identification of components responsible
 for the autologous humoral responses of ovarian cancer patients. American Journal of
 Reproductive Immunology, 6:179-184, 1984.
 D.D. Taylor and P.H. Black. Inhibition of macrophage Ia antigen expression by shed
 plasma membrane vesicles from metastatic murine melanoma lines. Journal of the
 National Cancer Institute, 74:859-867, 1985.
 ~ 50648620 </doc>


[User] <|image|>what words are in the image?

[Assistant]
<doc> To:
 From:
 Subject:
 PHILIP MORRIS U. S. A.
 INTER-OFFICE CORRESPONDENCE
 RICHHOND, VIRGINIA
 Those Listed aa Date: December 22, 1977
 CCNEIDENTIAL
 Leo F. Meyer
 Project BETA Meeting
 The weekly BETA meeting was held on Thursday, December 22, with
 representatives from Leaf, Manufacturing. and R&D.
 No up-date on HTI consumer testing was available. Data is expected
 next week.
 The new series of BETA samples was discussed (Table I). Large scale
 batches of Merit blend and Hi-ETA blend have been made. Cigarette prototypes
 are being made and sent to Analytical. Decision will be made next week (if
 tar levels suitable), to proceed to VP and HTI testing.
 Dr. Seligman suggested single stimulus testing of BETA prototypes be
 conducted to establish the position of BETA products versus consumers'
 normal brand. It was decided to first test Merit blind in single stimulus
 testing to establish a bench mark for such testing.
 Analysis of Saratogas from large scale factory BETA run showed ET
 variations from 17-30%, with an overall average of 23%. This appears to
 be the reason for the 7 mg tar delivery on these cigarettes. A new factory
 run will be instituted and cigarettes will be made from Saratogas having
 close to 30% ET to check tar deliveries.
 The in-house fermentation studies to establish where sorbate can be
 added have reached a temperature of 115° after 10 days. Analyses indicate
 initial low OV on these samples and low bacteria count on this tobacco.
 New fermentation runs will be scheduled.
 The next meeting was set for Friday, December 30, at 9:00 AM.
 P roye
 L. F. Meyer’)
 /bjn
 cc: Dr. R. B. Seligman Mr. K. F. Heidstieck
 Dr. W. F. Gannon Mr. H. L. Spielberg
 Dr. W. A. Farone Mr. Jd. van Harn
 Mr. J. A. Crichton Mr. K. D. Wood
 Mr. F. L. Daylor Mr. W. G. Lloyd
 Mr. C. N. Kounnas
 Mr. P. N. Gauvin
 GTSESTLS0G </doc>


[User] <|image|>Retrieve written information from the image.

[Assistant]
<doc> Respondent: Srnec { ssaick Date: gis YT ime: f 09
 co No Answer
 4 _2XX Left Full Message
 . =a ____ Contacted
 Outgoing Calis
 This is from the Consumer Opinion Center. May I speak to
 (consumer)?
 Hi, (consumer). Just a quick call to see if you’ve had an opportunity to
 smoke any of the Accord cigarettes?
 If Yes, then
 Any thoughts about the product that you want to mention at this time?
 Do you have any questions at this point?
 Are there any suggestions or comments regarding this study that you want
 to make at this time?
 Any other thoughts you want to mention at this time?
 We look forward to seeing you on (Day/Date) at (Time).
 If No, then
 That’s OK, when you use it, it is completely up to you. Do you think you’ll ,
 have a chance to try the Accord product before you come back on (Date).
 Either way, we look forward to seeing you on the ? Just bring
 in the kit, any unsmoked Accord cigarettes, your thoughts, and we’ll pay
 you $60.00.
 LP \e
 1¢90709902 </doc>